{"title":"In stock","description":"\u003cp\u003eProducts with units available today in our Madrid warehouse.\u003c\/p\u003e","products":[{"product_id":"profhilo","title":"Profhilo H+L 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eProfhilo® H+L from IBSA Derma is not a dermal filler: it is a bio-remodelling product based on \u003cb\u003enon-cross-linked\u003c\/b\u003e hyaluronic acid. Each 2 ml syringe delivers 64 mg of ultrapure hyaluronic acid — 32 mg of high molecular weight and 32 mg of low molecular weight — stabilised by NAHYCO® thermal technology, without any chemical cross-linking agent. It is applied with the fixed BAP protocol: 5 defined points per hemiface, 10 in total, in two sessions one month apart.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eNon-cross-linked HA\u003c\/b\u003e 64 mg \/ 2 ml (3.2 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eH-HA + L-HA\u003c\/b\u003e 32 mg + 32 mg\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 29G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e BAP, 10 points, 2 sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eHigh molecular weight hyaluronic acid (H-HA):\u003c\/b\u003e 32 mg per 2 ml syringe, with a molecular weight of 1,100–1,400 kDa.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLow molecular weight hyaluronic acid (L-HA):\u003c\/b\u003e 32 mg per 2 ml syringe, with a molecular weight of 80–100 kDa.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTotal concentration:\u003c\/b\u003e 64 mg \/ 2 ml, equivalent to 32 mg\/ml (3.2 %). Sodium salt of hyaluronic acid of microbial origin, obtained by biofermentation and without chemical modification.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eExcipients:\u003c\/b\u003e physiological solution buffered with sodium chloride, sodium phosphate and water for injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNAHYCO® technology:\u003c\/b\u003e patented thermal process of controlled heating and cooling that breaks the hydrogen bonds of the mixture and allows the formation of new bonds between the high and low molecular weight chains. The result is stable Hybrid Cooperative Complexes (\u003ci\u003eHybrid Cooperative Complexes\u003c\/i\u003e, HCC). \u003cb\u003eNeither BDDE nor any other chemical cross-linker is used\u003c\/b\u003e, unlike conventional hyaluronic acid fillers.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFunctional difference:\u003c\/b\u003e as it is not cross-linked, the product provides neither projection nor volume support. Its behaviour is that of a low-viscosity, highly diffusing gel, which distributes within the tissue plane instead of remaining localised like an implant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the Profhilo variants\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo H+L\u003c\/th\u003e\u003ctd\u003e64 mg \/ 2 ml (32 mg H-HA + 32 mg L-HA) — laxity and remodelling of the facial contour, dermal\/subcutaneous plane, BAP technique with a 29G needle\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo Structura\u003c\/th\u003e\u003ctd\u003e90 mg \/ 2 ml (45 mg H-HA + 45 mg L-HA) — volume loss due to atrophy of facial adipose tissue, superficial fat compartment, application with a cannula\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo Body\u003c\/th\u003e\u003ctd\u003e96 mg \/ 3 ml per syringe, 2 syringes — body skin laxity (abdomen, inner surface of the arms, knees), body BAP technique at 10 points\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eAll three variants share NAHYCO® technology and the absence of a chemical cross-linker. They differ in concentration, application plane and pattern of points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable medical device indicated, according to the manufacturer's instructions for use, for the \u003cb\u003etreatment of the malar-zygomatic and submalar areas of the face, for the redefinition of the contour and the remodelling of skin laxity\u003c\/b\u003e.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMalar and zygomatic region\u003c\/li\u003e\n\u003cli\u003eSubmalar region\u003c\/li\u003e\n\u003cli\u003eMandibular angle and chin, within the BAP point scheme\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProfhilo H+L is not indicated for the correction of individual wrinkles or for volumetric restoration; cross-linked fillers are used for that purpose or, in the case of adipose atrophy, Profhilo Structura.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol — BAP points\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe \u003cb\u003eBAP\u003c\/b\u003e protocol (\u003ci\u003eBio Aesthetic Points\u003c\/i\u003e) defines five anatomically fixed injection points per hemiface, selected for their low vascular risk and their diffusion capacity. \u003cb\u003e0.2 ml per point\u003c\/b\u003e is injected as a bolus, in the dermal\/subcutaneous plane, with gentle massage afterwards.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003e1 — Zygomatic prominence:\u003c\/b\u003e highest point of the zygomatic arch, approximately 2 cm from the lateral canthus of the eye.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e2 — Nasal base:\u003c\/b\u003e intersection between the horizontal line running from the nasal ala towards the tragus and the perpendicular descending from the pupil.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e3 — Tragus:\u003c\/b\u003e approximately 1 cm in front of the lower margin of the tragus.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e4 — Mandibular angle:\u003c\/b\u003e around 1 cm above the angle of the mandible.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e5 — Chin:\u003c\/b\u003e approximately 1.5 cm towards the oral commissure from the mental reference point.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 1 ml per hemiface, maximum 2 ml (10 points) per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 29G ½\" (0.33 × 12 mm), 2 units included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInitial cycle:\u003c\/b\u003e two sessions with an interval of 30 days, with the same dose and the same points in both.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaintenance:\u003c\/b\u003e the manufacturer provides for maintenance sessions from 2 months onwards, with a maximum of seven treatments over a 12-month period.\u003c\/li\u003e\n\u003cli\u003eAfter injection, it is recommended to avoid exposure to ultraviolet radiation for 3–5 days and to use SPF 50 sun protection.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eIBSA Derma — IBSA Farmaceutici Italia \/ IBSA Institut Biochimique SA, Switzerland\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eSodium salt of non-cross-linked hyaluronic acid, 64 mg \/ 2 ml (32 mg\/ml)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eFractions\u003c\/th\u003e\u003ctd\u003e32 mg H-HA (1,100–1,400 kDa) + 32 mg L-HA (80–100 kDa)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin\u003c\/th\u003e\u003ctd\u003eMicrobial biofermentation, without chemical modification\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eNone — NAHYCO® thermal stabilisation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eNot contained\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 29G ½\" (0.33 × 12 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eDermal \/ subcutaneous (intradermal use)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ ethylene oxide (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device for intradermal use\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 0 °C and 25 °C, away from heat sources. \u003cb\u003eDo not freeze.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise. Sterile and pyrogen-free contents.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2.0 ml, 2 needles 29G ½\", instructions for use and traceability labels for the patient record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eManufacturer's warnings:\u003c\/b\u003e for intradermal use only. Do not inject intravenously, intramuscularly or into tendons. Do not mix with other products in the same syringe. It must not be used concomitantly with laser \u003ci\u003eresurfacing\u003c\/i\u003e treatments or with medium-to-deep peels.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to hyaluronic acid or to any of the components; active skin infection or inflammation in the treatment area; pregnancy and breastfeeding; patients under 18 years of age. Individual assessment in patients with autoimmune disease, coagulation disorders or anticoagulant therapy.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the instructions for use and the official documentation of IBSA Derma. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"IBSA","offers":[{"title":"Default Title","offer_id":51007627788628,"sku":null,"price":79.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/profhio_hl.jpg?v=1746786717"},{"product_id":"ejal40","title":"EJAL40 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eEJAL40 is a biorevitalisation gel based on non-cross-linked hyaluronic acid, presented in a single-dose 2 ml vial, intended to improve skin quality, hydration and elasticity. This data sheet has been drafted restrictively: it has not been possible to verify the manufacturer's technical documentation for this reference, so concentrations and numerical protocols are deliberately omitted.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eActive substance\u003c\/b\u003e non-cross-linked HA\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 vial × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eUse\u003c\/b\u003e biorevitalisation\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRoute\u003c\/b\u003e intradermal\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eEJAL40 is a solution of non-cross-linked hyaluronic acid for skin biorevitalisation. As it is not cross-linked, the product does not provide structural volume: it acts by improving dermal hydration and skin quality.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eNote on the figures:\u003c\/b\u003e the hyaluronic acid concentration and the molecular weight could not be verified in the manufacturer's official documentation and, as an editorial policy, are not reproduced here. For the binding detail, consult the package leaflet accompanying the product or request the manufacturer's technical data sheet from us.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eUsual indications for this product category:\u003c\/b\u003e skin dehydration, loss of elasticity and firmness, dull skin, fine lines and early signs of photoageing.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFace\u003c\/li\u003e\n\u003cli\u003eNeck and décolletage\u003c\/li\u003e\n\u003cli\u003eDorsum of the hands\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable product for intradermal administration by microinjections (mesotherapy, microdeposits or linear retrograde threading, according to medical assessment), on healthy and rigorously disinfected skin, under aseptic conditions.\u003c\/p\u003e\n\u003cp\u003eWe have no manufacturer's documentation establishing the needle gauge, the dose per session, the number of sessions or the interval between them. The binding protocol is the one set out in the instructions for use included in the pack.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eBrand\u003c\/th\u003e\u003ctd\u003eEJAL40\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eNon-cross-linked hyaluronic acid (concentration not verified)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 vial of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eNot verified in the manufacturer's documentation; consult the packaging labelling\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e1 sterile vial of 2 ml.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise.\u003c\/li\u003e\n\u003cli\u003eStore as indicated on the packaging, protected from direct sunlight.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eGeneral precautions applicable to intradermal injectables: known hypersensitivity to any of the components; active skin infection, inflammation or lesion in the treatment area; coagulation disorders; autoimmune diseases; pregnancy and breastfeeding; under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eThe binding contraindications are exclusively those set out in the official documentation accompanying the product. Always consult it before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eProduct intended exclusively for qualified healthcare professionals. For this reference no public technical documentation from the manufacturer has been found; the data sheet has been drafted restrictively and deliberately omits values that cannot be verified. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Medixa","offers":[{"title":"Default Title","offer_id":51007628018004,"sku":null,"price":36.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/ejal40_d059a522-a1cf-47e3-a2a1-5d9bfd4af251.jpg?v=1747749687"},{"product_id":"11932","title":"Belotero Balance Lidocaine 1x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eBELOTERO® Balance Lidocaine is the versatile filler of the Merz Aesthetics range: a cross-linked sodium hyaluronate gel at 22.5 mg\/ml manufactured with CPM® technology (Cohesive Polydensified Matrix), a matrix of variable cross-linking density that integrates into the tissue rather than behaving as a particulate gel. It is the only reference in the range with an Instructions for Use indication for the infraorbital hollow, including the tear troughs.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 22.5 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 27G ½\" and 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e up to 18 months (infraorbital hollow)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked sodium hyaluronate:\u003c\/b\u003e 22.5 mg\/ml, of non-animal origin, high molecular weight (2.7–3.3 m³\/kg).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml (0.3 %), to reduce local pain associated with injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e 1,4-butanediol diglycidyl ether (BDDE), degree of modification \u0026lt; 8 %. Residual BDDE ≤ 2 ppm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhysiological phosphate buffer pH 7\u003c\/b\u003e q.s. to 1 ml, with sodium chloride 8 mg\/ml, sodium dihydrogen phosphate dihydrate 0.5 mg\/ml and disodium phosphate dodecahydrate 2.4 mg\/ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCPM® technology:\u003c\/b\u003e the gel presents variable cross-linking densities within a single monophasic phase. The denser gel zones fill and expand the tissue, while the lower-density zones diffuse into the fine pericellular spaces. Hence its homogeneous intradermal distribution and its tolerance of superficial planes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the BELOTERO® range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eSoft Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml · modification \u0026lt; 5 % · superficial to mid dermis · fine perioral lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eBalance Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 22.5 mg\/ml · modification \u0026lt; 8 % · superficial to mid dermis and infraorbital supraperiosteal plane · moderate wrinkles and folds, lips, infraorbital hollow\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIntense Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · modification \u0026lt; 8 % · deep dermis · deep folds, marionette lines, lip enhancement\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLips Shape\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · deep dermis and labial mucosa · volume and vermilion border\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVolume Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 26 mg\/ml · modification \u0026lt; 10 % · deep subcutaneous or supraperiosteal · cheeks, temples, chin, severe NLFs\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRevive\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml + glycerol 17.5 mg\/ml · mid and deep dermis · skin revitalisation, not volumetric filling\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe progression of the range is defined not only by HA concentration, but by the degree of modification of the cross-linker and, consequently, by the injection plane for which each gel is intended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eBiodegradable injectable implant indicated for filling facial wrinkles and folds and for volume enhancement, in adults.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eSuperficial to mid dermis:\u003c\/b\u003e nasolabial folds, marionette lines, perioral lines, horizontal forehead lines and oral commissures.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSubmucosal or subcutaneous:\u003c\/b\u003e lip enhancement.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSupraperiosteal plane:\u003c\/b\u003e filling of the infraorbital hollow, including the tear troughs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eMust not be injected\u003c\/b\u003e into the glabellar or nasal region, into blood vessels, into skin with active inflammation or infection, or into areas previously treated with a permanent filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDuration documented by the manufacturer\u003c\/b\u003e according to clinical data: nasolabial folds up to 12 months; horizontal forehead lines up to 6 months; lip enhancement, including the contour, up to 6 months; perioral lines and oral commissures up to 4 months; infraorbital hollow, including the tear troughs, up to 18 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 1 × 27G ½\" and 1 × 30G ½\". The 30G ½\" needle requires greater injection force. A sterile 27G blunt cannula may also be used at the practitioner's discretion.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e linear or serial threading, fanning, cross-hatching and serial (micro)puncture. Balance permits the blanching technique (very superficial infiltration).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInfraorbital hollow:\u003c\/b\u003e inject deeply onto the bone, in the supraperiosteal plane, beneath the orbicularis muscle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReduction of vascular risk:\u003c\/b\u003e prior aspiration, low volumes and serial injections in high-risk areas, treating one side at a time and manual occlusion of the origin of the supratrochlear vessels.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaximum volume:\u003c\/b\u003e 8.0 ml per session for the whole face (equivalent to 24 mg of lidocaine); maximum annual dose 16.0 ml. Treatments in the same anatomical region must be separated by at least 2 weeks.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaximum volumes per indication:\u003c\/b\u003e nasolabial folds up to 4.8 ml; marionette lines and oral commissures up to 3.0 ml; perioral lines up to 1.0 ml; lips up to 1.5 ml; horizontal forehead lines up to 5.5 ml; infraorbital hollow up to 3.0 ml (maximum 1 ml per side and session).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCombination:\u003c\/b\u003e must not be combined with peeling, dermabrasion or laser before complete healing and, in any case, not before 2 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAnteis SA, Chemin des Aulx 18, 1228 Plan-les-Ouates, Switzerland (Merz Aesthetics)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEU representative\u003c\/th\u003e\u003ctd\u003eMerz Aesthetics GmbH, Frankfurt am Main, Germany\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked sodium hyaluronate 22.5 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE, degree of modification \u0026lt; 8 %; residual ≤ 2 ppm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eCPM® (Cohesive Polydensified Matrix)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7 (physiological phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled plastic syringe of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e1 × 27G ½\" and 1 × 30G ½\" (TSK Laboratory, Japan)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ sterile CE-marked needles\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0123 in accordance with Regulation (EU) 2017\/745; product without an intended medical purpose (Implementing Regulation (EU) 2022\/2346)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C. Protect from light. Do not freeze. Store in a dry place and avoid mechanical impact.\u003c\/li\u003e\n\u003cli\u003eVisually inspect the integrity of the packaging and of the sterile barrier system before use. Do not use after the expiry date.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not resterilise or reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.0 ml, 2 sterile needles (27G ½\" and 30G ½\"), traceability labels, implant card, instructions for use and patient information leaflet.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to any of the components, in particular to sodium hyaluronate, to BDDE, to lidocaine hydrochloride or to other amide-type local anaesthetics; pregnancy and breastfeeding; under 18 years of age; general infection; active autoimmune disease.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not inject\u003c\/b\u003e into blood vessels, into the glabellar or nasal region, into skin with active inflammation or infection, or into areas treated with a permanent dermal filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e rare but serious events associated with intravascular injection of facial fillers have been reported — vascular occlusion, visual impairment, blindness, cerebral ischaemia or haemorrhage, skin necrosis. Stop the injection immediately in the event of changes in vision, signs of stroke, skin blanching or unusual pain, and refer for urgent medical care. Sodium hyaluronate precipitates in the presence of quaternary ammonium salts (e.g. benzalkonium chloride).\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions:\u003c\/b\u003e individual assessment in cases of a history of multiple severe allergies or anaphylactic shock, epilepsy, cardiac disease, severe hepatic or renal impairment and porphyria; not recommended in cases of a history of streptococcal disease or a tendency to hypertrophic or keloid scarring; anticoagulants, antiplatelet agents and NSAIDs increase the risk of haematoma; lidocaine may give a positive result in anti-doping tests. Injection into the infraorbital hollow is associated with a greater frequency, duration or severity of local side effects.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of BELOTERO® Balance Lidocaine (Anteis SA \/ Merz Aesthetics, Spanish version V05, 23-02-2026). This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Merz Aesthetics","offers":[{"title":"Default Title","offer_id":51007628378452,"sku":null,"price":84.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/belotero_balance_lidocaine.jpg?v=1747767479"},{"product_id":"belotero-intense","title":"Belotero Intense Lidocaine 1x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eBELOTERO® Intense Lidocaine is the deep dermis gel of the Merz Aesthetics range: cross-linked sodium hyaluronate at 25.5 mg\/ml with CPM® technology, intended to fill deep facial wrinkles and folds and to restore and enhance the soft tissue. It differs from Balance in its higher concentration and in the injection plane; from Volume, in its indication — folds and lips, not volumetric restoration of the middle third.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 25.5 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 27G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e up to 12 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked sodium hyaluronate:\u003c\/b\u003e 25.5 mg\/ml, of non-animal origin, high molecular weight (2.7–3.0 m³\/kg).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml (0.3 %).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e BDDE, degree of modification \u0026lt; 8 %. Residual BDDE ≤ 10 ppm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhysiological phosphate buffer pH 7\u003c\/b\u003e q.s. to 1 ml, with sodium chloride 8 mg\/ml, sodium dihydrogen phosphate dihydrate 0.5 mg\/ml and disodium phosphate dodecahydrate 2.4 mg\/ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCPM® technology:\u003c\/b\u003e monophasic gel of variable cross-linking density. The denser zones provide filling and structural support; the lower-density zones diffuse into the fine pericellular spaces, which allows homogeneous tissue integration even in high-concentration gels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the BELOTERO® range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eSoft Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml · modification \u0026lt; 5 % · superficial to mid dermis · fine perioral lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eBalance Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 22.5 mg\/ml · modification \u0026lt; 8 % · superficial to mid dermis and infraorbital supraperiosteal plane · moderate wrinkles and folds, lips, infraorbital hollow\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIntense Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · modification \u0026lt; 8 % · deep dermis · deep folds, marionette lines, lip enhancement\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLips Shape\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · deep dermis and labial mucosa · volume and vermilion border\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVolume Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 26 mg\/ml · modification \u0026lt; 10 % · deep subcutaneous or supraperiosteal · cheeks, temples, chin, severe NLFs\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRevive\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml + glycerol 17.5 mg\/ml · mid and deep dermis · skin revitalisation, not volumetric filling\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eIntense and Lips Shape share the same concentration (25.5 mg\/ml); the difference lies in the intended use and in the presentation: Lips Shape is directed specifically at the labial mucosa and the vermilion border.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eBiodegradable injectable implant created to fill deep facial wrinkles and folds and to restore and enhance the soft tissue, in adults.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eDeep dermis:\u003c\/b\u003e nasolabial folds and marionette lines.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSubmucosal or subcutaneous:\u003c\/b\u003e lip enhancement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eMust not be injected\u003c\/b\u003e into the glabellar or nasal region, into blood vessels, into skin with active inflammation or infection, or into areas previously treated with a permanent filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e up to 12 months in nasolabial folds and marionette lines, and up to 3 months in lip enhancement, according to the manufacturer's clinical data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 2 × 27G ½\". A smaller needle diameter requires greater injection force.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e deep dermis; submucosal or subcutaneous for the lips.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e linear or serial threading, fanning, cross-hatching and serial (micro)puncture.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e the practitioner must be familiar with the distribution of the labial arteries. Reduce the risk by prior aspiration, low volumes, serial injections in high-risk areas and treating one side at a time.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaximum volume:\u003c\/b\u003e 7 ml per session (equivalent to 21 mg of lidocaine); maximum annual dose 14 ml. Treatments in the same anatomical region must be separated by at least 2 weeks.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCombination:\u003c\/b\u003e must not be combined with peeling, dermabrasion or laser before complete healing and, in any case, not before 2 weeks. It may be used with other BELOTERO products in the same session, but in different facial areas.\u003c\/li\u003e\n\u003cli\u003eDo not overcorrect. Gently massage the treated area if necessary.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAnteis SA, Chemin des Aulx 18, 1228 Plan-les-Ouates, Switzerland (Merz Aesthetics)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEU representative\u003c\/th\u003e\u003ctd\u003eMerz Aesthetics GmbH, Frankfurt am Main, Germany\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked sodium hyaluronate 25.5 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE, degree of modification \u0026lt; 8 %; residual ≤ 10 ppm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eCPM® (Cohesive Polydensified Matrix)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7 (physiological phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled plastic syringe of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 27G ½\"\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ sterile CE-marked needles\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0123 in accordance with Regulation (EU) 2017\/745; product without an intended medical purpose (Implementing Regulation (EU) 2022\/2346)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C. Protect from light. Do not freeze. Store in a dry place and avoid mechanical impact.\u003c\/li\u003e\n\u003cli\u003eVisually inspect the integrity of the packaging and of the sterile barrier system before use. Do not use after the expiry date.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not resterilise or reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.0 ml, 2 sterile 27G ½\" needles, traceability labels, implant card, instructions for use and patient information leaflet.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to any of the components, in particular to sodium hyaluronate, to BDDE, to lidocaine hydrochloride or to other amide-type local anaesthetics; pregnancy and breastfeeding; under 18 years of age; general infection; active autoimmune disease.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not inject\u003c\/b\u003e into blood vessels, into the glabellar or nasal region, into skin with active inflammation or infection, or into areas treated with a permanent dermal filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e rare but serious events associated with intravascular injection of facial fillers have been reported — vascular occlusion, visual impairment, blindness, cerebral ischaemia or haemorrhage, skin necrosis. Stop the injection immediately in the event of changes in vision, signs of stroke, skin blanching or unusual pain. Sodium hyaluronate precipitates in the presence of quaternary ammonium salts (e.g. benzalkonium chloride).\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions:\u003c\/b\u003e individual assessment in cases of a history of multiple severe allergies or anaphylactic shock, epilepsy, cardiac disease, severe hepatic or renal impairment and porphyria; not recommended in cases of a history of streptococcal disease or a tendency to hypertrophic or keloid scarring; anticoagulants, antiplatelet agents and NSAIDs increase the risk of haematoma; lidocaine may give a positive result in anti-doping tests. The risk of granuloma, ischaemia, necrosis and vascular occlusion is greater with deep injections and high volumes.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of BELOTERO® Intense Lidocaine (Anteis SA \/ Merz Aesthetics, Spanish version V04, 23-02-2026). This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Merz Aesthetics","offers":[{"title":"Default Title","offer_id":51007628706132,"sku":null,"price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/belotero_intense_lidocaine_a200a62c-dbf2-401a-9dd6-99fc7bf4159a.jpg?v=1747767003"},{"product_id":"belotero-soft-lidocaina","title":"Belotero Soft Lidocaine 1x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eBELOTERO® Soft Lidocaine is the least cross-linked gel of the Merz Aesthetics range: sodium hyaluronate at 20 mg\/ml with a BDDE degree of modification below 5 %, formulated with CPM® technology for injection into the superficial to mid dermis. Its Instructions for Use indication is specific: fine perioral lines.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 20 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e at least 6 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked sodium hyaluronate:\u003c\/b\u003e 20 mg\/ml, of non-animal origin, high molecular weight (2.7–3.3 m³\/kg).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml (0.3 %).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e BDDE, degree of modification \u0026lt; 5 % — the lowest in the range. Residual BDDE ≤ 2 ppm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhysiological phosphate buffer pH 7\u003c\/b\u003e q.s. to 1 ml, with sodium chloride 8 mg\/ml, sodium dihydrogen phosphate dihydrate 0.5 mg\/ml and disodium phosphate dodecahydrate 2.4 mg\/ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCPM® technology:\u003c\/b\u003e monophasic matrix of variable cross-linking density. The denser gel fractions fill the tissue and the lower-density ones diffuse into the fine pericellular spaces, which allows a homogeneous distribution in superficial planes without an accumulation effect.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the BELOTERO® range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eSoft Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml · modification \u0026lt; 5 % · superficial to mid dermis · fine perioral lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eBalance Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 22.5 mg\/ml · modification \u0026lt; 8 % · superficial to mid dermis and infraorbital supraperiosteal plane · moderate wrinkles and folds, lips, infraorbital hollow\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIntense Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · modification \u0026lt; 8 % · deep dermis · deep folds, marionette lines, lip enhancement\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLips Shape\u003c\/th\u003e\u003ctd\u003eHA 25.5 mg\/ml · deep dermis and labial mucosa · volume and vermilion border\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVolume Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 26 mg\/ml · modification \u0026lt; 10 % · deep subcutaneous or supraperiosteal · cheeks, temples, chin, severe NLFs\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRevive\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml + glycerol 17.5 mg\/ml · mid and deep dermis · skin revitalisation, not volumetric filling\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eSoft and Revive share the same HA concentration (20 mg\/ml) and degree of modification (\u0026lt; 5 %), but differ in purpose: Soft is a filler for fine lines; Revive is a revitaliser with glycerol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eBiodegradable injectable implant created to fill perioral expression lines in adults.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInstructions for Use indication:\u003c\/b\u003e injection into the superficial to mid dermis for the treatment of fine perioral lines.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eMust not be injected\u003c\/b\u003e into the glabellar or nasal region, into blood vessels, into skin with active inflammation or infection, or into areas previously treated with a permanent filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e at least 6 months according to the manufacturer's clinical data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 2 × 30G ½\". Use of the supplied needles is recommended.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial to mid dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e linear or serial threading, fanning, cross-hatching and serial (micro)puncture.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReduction of vascular risk:\u003c\/b\u003e prior aspiration, low volumes and serial injections in high-risk areas, treating one side at a time, pinching or stretching the skin and manual occlusion of the origin of the supratrochlear vessels.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaximum volume:\u003c\/b\u003e 3 ml per session (equivalent to 9 mg of lidocaine). The treatment of perioral lines may be repeated after 6 months. Treatments in the same anatomical region must be separated by at least 2 weeks.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCombination:\u003c\/b\u003e must not be combined with peeling, dermabrasion or laser before complete healing and, in any case, not before 2 weeks.\u003c\/li\u003e\n\u003cli\u003eDo not overcorrect. Gently massage the treated area if necessary to distribute the product evenly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAnteis SA, Chemin des Aulx 18, 1228 Plan-les-Ouates, Switzerland (Merz Aesthetics)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEU representative\u003c\/th\u003e\u003ctd\u003eMerz Aesthetics GmbH, Frankfurt am Main, Germany\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked sodium hyaluronate 20 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE, degree of modification \u0026lt; 5 %; residual ≤ 2 ppm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eCPM® (Cohesive Polydensified Matrix)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7 (physiological phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled plastic syringe of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\"\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ sterile CE-marked needles\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0123 in accordance with Regulation (EU) 2017\/745; product without an intended medical purpose (Implementing Regulation (EU) 2022\/2346)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C. Protect from light. Do not freeze. Store in a dry place and avoid mechanical impact.\u003c\/li\u003e\n\u003cli\u003eVisually inspect the integrity of the packaging and of the sterile barrier system before use. Do not use after the expiry date.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not resterilise or reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.0 ml, 2 sterile 30G ½\" needles, traceability labels, implant card, instructions for use and patient information leaflet.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to any of the components, in particular to sodium hyaluronate, to BDDE, to lidocaine hydrochloride or to other amide-type local anaesthetics; pregnancy and breastfeeding; under 18 years of age; general infection; active autoimmune disease.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not inject\u003c\/b\u003e into blood vessels, into the glabellar or nasal region, into skin with active inflammation or infection, or into areas treated with a permanent dermal filler.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e rare but serious events associated with intravascular injection of facial fillers have been reported — vascular occlusion, visual impairment, blindness, cerebral ischaemia or haemorrhage, skin necrosis. Stop the injection immediately in the event of changes in vision, signs of stroke, skin blanching or unusual pain. Sodium hyaluronate precipitates in the presence of quaternary ammonium salts (e.g. benzalkonium chloride).\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions:\u003c\/b\u003e individual assessment in cases of a history of multiple severe allergies or anaphylactic shock, epilepsy, cardiac disease, severe hepatic or renal impairment and porphyria; not recommended in cases of a history of streptococcal disease or a tendency to hypertrophic or keloid scarring; anticoagulants, antiplatelet agents and NSAIDs increase the risk of haematoma; lidocaine may give a positive result in anti-doping tests.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of BELOTERO® Soft Lidocaine (Anteis SA \/ Merz Aesthetics, Spanish version V04, 23-02-2026). This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Merz Aesthetics","offers":[{"title":"Default Title","offer_id":51007629361492,"sku":null,"price":78.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/belotero_soft_lidocaine.jpg?v=1747766491"},{"product_id":"juvederm-ultra-3","title":"Juvederm Ultra 3 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eJuvéderm® ULTRA 3 is the intermediate gel of the HYLACROSS™ range from Allergan Aesthetics: cross-linked hyaluronic acid at 24 mg\/ml with lidocaine, in 1 ml syringes with a 27G needle. Its instructions for use indicate it for filling medium and\/or deep cutaneous depressions by injection into the mid and\/or deep dermis, as well as for lip definition and augmentation. It is the versatile reference of the ULTRA range for the nasolabial fold and marionette lines.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 24 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 × 27G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e mid and\/or deep dermis\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid gel:\u003c\/b\u003e 24 mg per ml, of non-animal origin (obtained by bacterial fermentation).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg per ml (0.3 %), included to reduce patient pain during treatment.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer\u003c\/b\u003e pH 7.2 q.s. to 1 ml.\u003c\/li\u003e\n\u003cli\u003eSterile, pyrogen-free physiological solution in a graduated single-use pre-filled syringe. Each syringe contains 1 ml of product.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHYLACROSS™ technology:\u003c\/b\u003e Allergan's designation for its monophasic, homogeneous HA gels at 24 mg\/ml, the basis of the whole Juvéderm® ULTRA range. Compared with VYCROSS® technology (Volbella, Volift, Voluma, Volux, SkinVive), which combines high- and low-molecular-weight HA at concentrations from 12 to 25 mg\/ml, HYLACROSS™ maintains a single concentration of 24 mg\/ml in all its variants: what separates ULTRA 2, 3, 4 and SMILE is the degree of gel cross-linking and, consequently, the indicated injection depth and the needle gauge supplied.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eULTRA 3 occupies the central position of the HYLACROSS™ range: the same 24 mg\/ml gel as ULTRA 2, but with sufficient cross-linking to work in the deep dermis as well, in a 1 ml syringe and with a larger-gauge needle (27G instead of 30G).\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA 2\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 0.55 ml · 30G½\" · mid dermis · medium-sized depressions and lip definition\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003e\u003cb\u003eJuvéderm® ULTRA 3 — this product\u003c\/b\u003e\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 1 ml · 27G½\" · mid and\/or deep dermis · medium and deep depressions, lip definition and augmentation\u003c\/b\u003e\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA 4\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 1 ml · 27G½\" · deep dermis · deep depressions, lip augmentation and cheekbone augmentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA SMILE\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 0.55 ml · 30G½\" · mid and\/or deep dermis · lip definition and augmentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSKINVIVE™ by Juvéderm® (formerly VOLITE™)\u003c\/th\u003e\u003ctd\u003eHA 12 mg\/ml · VYCROSS® · 2 × 1 ml · 32G½\" · intradermal · skin quality: hydration, elasticity, fine lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLBELLA®\u003c\/th\u003e\u003ctd\u003eHA 15 mg\/ml · VYCROSS® · 2 × 1 ml · 32G½\" · superficial\/mid dermis and labial mucosa · fine lines, lips and infraorbital region\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLIFT®\u003c\/th\u003e\u003ctd\u003eHA 17.5 mg\/ml · VYCROSS® · 2 × 1 ml · 30G½\" · deep dermis or labial mucosa · deep depressions, facial contouring, lips\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLUMA®\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml · VYCROSS® · 2 × 1 ml · 27G½\" · subcutaneous, supraperiosteal or deep dermis · facial volume restoration\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLUX™\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml · VYCROSS® · 2 × 1 ml · 27G½\" · subcutaneous and supraperiosteal · restoring and creating volume (chin and jawline)\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eWhen to choose ULTRA 3 over its neighbours:\u003c\/b\u003e compared with ULTRA 2, when the depression is deep as well as medium and a full millilitre per syringe is required. Compared with ULTRA 4, when the objective remains the cutaneous fold and lip definition rather than cheekbone volumising — ULTRA 4 is the only product in the ULTRA range whose indication includes cheekbone augmentation. Compared with VOLIFT (17.5 mg\/ml, VYCROSS®), when the higher HA concentration of HYLACROSS™ and the indication for the mid dermis as well as the deep dermis are preferred.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable implant indicated for filling medium and\/or deep cutaneous depressions by injection into the mid and\/or deep dermis, as well as for lip definition and augmentation.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMedium and deep cutaneous depressions (nasolabial fold, marionette lines)\u003c\/li\u003e\n\u003cli\u003eLip definition and augmentation\u003c\/li\u003e\n\u003cli\u003eLabial mucosa\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eContraindicated areas:\u003c\/b\u003e periorbital region (eyelids, crow's feet) and glabellar region (forehead). Application in the tear trough area must be performed only by a specialist with specific training in this technique. It is not indicated for breast augmentation or reconstruction.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eRoute of administration:\u003c\/b\u003e intradermal injections and injections into the labial mucosa only.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 4 units of 27G ½\", sterilised by irradiation, for exclusive use with this product.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAspiration beforehand:\u003c\/b\u003e after inserting the needle and before injecting, it is recommended to withdraw the plunger slightly to verify that the needle is not intravascular.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eImmediate blanching:\u003c\/b\u003e stop the injection and massage the area until normal colour returns.\u003c\/li\u003e\n\u003cli\u003eInject slowly and with the minimum pressure necessary. If the needle becomes blocked, do not increase pressure on the plunger: stop the injection and replace the needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eManufacturer's annual limit:\u003c\/b\u003e no safety data are available for the injection of more than 20 ml of Allergan dermal fillers per 60 kg of body weight per year.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInterval between sessions:\u003c\/b\u003e wait for side effects to resolve, with a minimum interval of 2 weeks between two injections.\u003c\/li\u003e\n\u003cli\u003eDo not overcorrect: injecting an excessive volume may cause tissue necrosis and oedema.\u003c\/li\u003e\n\u003cli\u003eMassage the treated area after injection to ensure uniform distribution of the product.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration of correction:\u003c\/b\u003e Allergan's instructions for use do not publish a duration figure for the ULTRA range; the degree and duration of correction depend on the type of defect treated, the tissue stress at the implant site, the depth of the implant and the injection technique.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAftercare:\u003c\/b\u003e no make-up for the following 12 hours; avoid prolonged exposure to the sun and to UV rays, temperatures below 0 °C, sauna and hammam for the following two weeks.\u003c\/li\u003e\n\u003cli\u003eThe composition of the product is compatible with the magnetic fields used in magnetic resonance imaging.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAllergan Aesthetics \/ AbbVie — Route de Promery, Zone Artisanale de Pré-Mairy, Pringy, 74370 Annecy (France)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles manufactured by\u003c\/th\u003e\u003ctd\u003eTSK Laboratory, Tochigi (Japan)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive ingredient\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid of non-animal origin, 24 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eBuffer\u003c\/th\u003e\u003ctd\u003ePhosphate, pH 7.2\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eHYLACROSS™\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 graduated pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 × 27G ½\"\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute \/ plane\u003c\/th\u003e\u003ctd\u003eIntradermal (mid and\/or deep dermis) and labial mucosa\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked class III implantable medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals with specific training in injection techniques only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C. Fragile product. Do not use after the expiry date stated on the label.\u003c\/li\u003e\n\u003cli\u003eDo not use the syringe if the contents show signs of separation or a cloudy appearance.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise: sterility cannot be guaranteed after reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSterilisation:\u003c\/b\u003e syringe contents by moist heat; needles by irradiation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack includes:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, 4 sterile needles of 27G ½\", instruction leaflet and a set of traceability labels.\u003c\/li\u003e\n\u003cli\u003eUsed needles must be disposed of in appropriate containers; never straighten a bent needle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e untreated epilepsy; tendency to hypertrophic scarring; known hypersensitivity to hyaluronic acid or to Gram-positive bacterial proteins (the HA is obtained from bacteria of the genus \u003ci\u003eStreptococcus\u003c\/i\u003e); hypersensitivity to lidocaine or to amide-type local anaesthetics; porphyria; pregnancy and breastfeeding; minors. Do not inject into areas with inflammatory or infectious skin processes (acne, herpes). Do not inject intravascularly. Do not overcorrect.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eIncompatibilities:\u003c\/b\u003e hyaluronic acid is incompatible with quaternary ammonium salts such as benzalkonium chloride; avoid all contact with these substances or with instruments treated with them. No interactions with other local anaesthetics are known.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions and individual assessment:\u003c\/b\u003e there are no clinical data on efficacy and tolerance in patients with autoimmune disease, immunodeficiency or immunosuppressive therapy, nor in patients with a history of severe or multiple allergies — the indication is assessed case by case and a prior skin test is recommended; in case of a history of anaphylactic shock, it is recommended not to inject. Patients with a history of streptococcal disease (recurrent pharyngitis, acute rheumatic fever) should undergo a prior skin test. Warn patients on anticoagulant or antiplatelet therapy of the increased risk of bleeding and bruising. Because of the presence of lidocaine, combination with drugs that reduce or inhibit hepatic metabolism (cimetidine, beta blockers) is not recommended, and caution is advised in patients with cardiac conduction disorders.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not use simultaneously\u003c\/b\u003e with laser, deep chemical peels or dermabrasion. With superficial peels, do not inject if the inflammatory reaction generated is significant.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e serious adverse events have been reported in association with intravascular injection of facial dermal fillers — temporary or permanent visual impairment, blindness, cerebral ischaemia or haemorrhage with stroke, skin necrosis and injury to underlying structures. Stop the injection immediately in the event of any visual change, sign of stroke, skin pallor or unusual pain.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use enclosed in the packaging before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of Juvéderm® ULTRA 3 (Allergan Aesthetics \/ AbbVie) and, where indicated, on FDA approval dossiers and peer-reviewed scientific literature. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"Allergan","offers":[{"title":"Default Title","offer_id":51007630082388,"sku":null,"price":164.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/juvederm-ultra3_600x_6ebd4310-05bd-4fd3-b251-2b52d0d896b7.webp?v=1735927935"},{"product_id":"juvederm-volbella","title":"Juvederm Volbella 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eJuvéderm® VOLBELLA® with lidocaine is the lowest-density gel of the VYCROSS® range from Allergan Aesthetics for superficial dermal work: cross-linked hyaluronic acid at 15 mg\/ml with lidocaine and a 32G needle. Its instructions for use indicate it for fine lines and medium-sized cutaneous depressions, for lip augmentation and projection and — the only documented case in the range — for the treatment of the infraorbital depression (tear trough), with its own injection plane.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 15 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 × 32G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLips\u003c\/b\u003e 61.8 % responders at 12 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid gel:\u003c\/b\u003e 15 mg per ml, of non-animal origin. It is the lowest concentration in the Juvéderm® range together with SKINVIVE™ (12 mg\/ml).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg per ml (0.3 %), included to reduce patient pain during treatment.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer\u003c\/b\u003e pH 7.2 q.s. to 1 ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linking agent:\u003c\/b\u003e butanediol diglycidyl ether (BDDE) in trace amounts (\u0026lt; 2 ppm).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVYCROSS® technology:\u003c\/b\u003e a combination of high- and low-molecular-weight hyaluronic acid. The greater cross-linking efficiency makes it possible to maintain gel performance at a lower total HA concentration, with a homogeneous texture and lower water uptake — which in VOLBELLA® translates into a fluid gel, suitable for superficial planes and for areas of thin skin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eVOLBELLA® is the lowest-concentration VYCROSS® gel intended for filling (SKINVIVE™, at 12 mg\/ml, is not a volumiser but a skin quality treatment). It is the only product in the range with an infraorbital indication documented in its package insert.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA 2\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 0.55 ml · 30G½\" · mid dermis · medium-sized depressions and lip definition\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA 3\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 1 ml · 27G½\" · mid and\/or deep dermis · medium and deep depressions, lip definition and augmentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA 4\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 1 ml · 27G½\" · deep dermis · deep depressions, lip augmentation and cheekbone augmentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® ULTRA SMILE\u003c\/th\u003e\u003ctd\u003eHA 24 mg\/ml · HYLACROSS™ · 2 × 0.55 ml · 30G½\" · mid and\/or deep dermis · lip definition and augmentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSKINVIVE™ by Juvéderm® (formerly VOLITE™)\u003c\/th\u003e\u003ctd\u003eHA 12 mg\/ml · VYCROSS® · 2 × 1 ml · 32G½\" · intradermal · skin quality: hydration, elasticity, fine lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003e\u003cb\u003eJuvéderm® VOLBELLA® — this product\u003c\/b\u003e\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eHA 15 mg\/ml · VYCROSS® · 2 × 1 ml · 32G½\" · superficial\/mid dermis and labial mucosa · fine lines, lips and infraorbital region\u003c\/b\u003e\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLIFT®\u003c\/th\u003e\u003ctd\u003eHA 17.5 mg\/ml · VYCROSS® · 2 × 1 ml · 30G½\" · deep dermis or labial mucosa · deep depressions, facial contouring, lips\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLUMA®\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml · VYCROSS® · 2 × 1 ml · 27G½\" · subcutaneous, supraperiosteal or deep dermis · facial volume restoration\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJuvéderm® VOLUX™\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml · VYCROSS® · 2 × 1 ml · 27G½\" · subcutaneous and supraperiosteal · restoring and creating volume (chin and jawline)\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eWhen to choose VOLBELLA® over its neighbours:\u003c\/b\u003e compared with SKINVIVE™, when there is a depression to be filled (a marked fine line, tear trough, lip volume) and not merely a deficit in skin quality. Compared with VOLIFT® (17.5 mg\/ml), when working in the superficial or mid dermis rather than the deep dermis, and when a 32G needle is required. Compared with ULTRA 2 and ULTRA SMILE (24 mg\/ml, HYLACROSS™), when a more subtle result and a more fluid integration in thin skin are sought, or when the area is the infraorbital region — contraindicated or restricted throughout the ULTRA range.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable implant indicated for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFine lines and medium-sized cutaneous depressions associated with premature ageing\u003c\/li\u003e\n\u003cli\u003eLip augmentation and projection, and correction of structural lip defects such as asymmetries, contour deformities or volume loss\u003c\/li\u003e\n\u003cli\u003eInfraorbital cutaneous depressions (tear trough)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eInjection planes by area:\u003c\/b\u003e superficial or mid dermis and labial mucosa for lines and lips; submuscular \/ preperiosteal plane for treatment of the infraorbital region.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eContraindicated areas:\u003c\/b\u003e do not inject into the eyelids. It is not indicated for breast augmentation or reconstruction.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSpecific warning for the infraorbital region:\u003c\/b\u003e no clinical data are available on infraorbital treatment in patients with a pre-existing tendency to infraorbital oedema. The practitioner must assess the patient's medical history and infraorbital anatomy and physiology before indicating treatment, and must warn of the possible increased risk of prolonged oedema.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 4 units of 32G ½\", sterilised by irradiation, for exclusive use with this product.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAlternatives accepted by the manufacturer:\u003c\/b\u003e sterile 30G ½\" needle, or sterile 30G cannula — Easyflow System-20 of 30G × 19 mm (ref. 94323 \/ HPC30019ACSH) and 30G × 25 mm (ref. 94324 \/ HPC30025ACSH). If a cannula is used in the infraorbital region, use the introducer needle to create the entry point below the orbital rim.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInfraorbital region with a needle:\u003c\/b\u003e insert the needle below the orbital rim, perpendicular to the skin surface, and inject into the submuscular \/ preperiosteal plane.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAspiration beforehand:\u003c\/b\u003e after inserting the needle and before injecting, it is recommended to withdraw the plunger slightly to verify that the needle is not intravascular.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eImmediate blanching:\u003c\/b\u003e stop the injection and massage the area until normal colour returns.\u003c\/li\u003e\n\u003cli\u003eInject slowly and with the minimum pressure necessary. If the needle becomes blocked, do not increase pressure on the plunger: stop the injection and replace the needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eManufacturer's annual limit:\u003c\/b\u003e no safety data are available for the injection of more than 20 ml of Allergan dermal fillers per 60 kg of body weight per year.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInterval between sessions:\u003c\/b\u003e wait for side effects to resolve, with a minimum interval of 2 weeks between two injections.\u003c\/li\u003e\n\u003cli\u003eDo not overcorrect: injecting an excessive volume may cause tissue necrosis and oedema.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e in the pivotal study registered with the FDA for this same 15 mg\/ml formulation with 0.3 % lidocaine (Juvéderm® VOLBELLA® XC) — lip augmentation: 80.3 % responders at month 3 and 61.8 % at 12 months (n = 168); infraorbital region: 83.3 % responders at month 3 and 73.4 % at 12 months (n = 105).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAftercare:\u003c\/b\u003e no make-up for the following 12 hours; avoid prolonged exposure to the sun and to UV rays, temperatures below 0 °C, sauna and hammam for the following two weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAllergan Aesthetics \/ AbbVie — Route de Promery, Zone Artisanale de Pré-Mairy, Pringy, 74370 Annecy (France)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles manufactured by\u003c\/th\u003e\u003ctd\u003eTSK Laboratory, Tochigi (Japan)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive ingredient\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid of non-animal origin, 15 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linking agent\u003c\/th\u003e\u003ctd\u003eBDDE in trace amounts (\u0026lt; 2 ppm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eBuffer\u003c\/th\u003e\u003ctd\u003ePhosphate, pH 7.2\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eVYCROSS®\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 graduated pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 × 32G ½\" (alternative: 30G ½\" or 30G cannula)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute \/ plane\u003c\/th\u003e\u003ctd\u003eSuperficial or mid dermis and labial mucosa; submuscular \/ preperiosteal in the infraorbital region\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked class III implantable medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals with specific training in injection techniques only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C. Fragile product. Do not use after the expiry date stated on the label.\u003c\/li\u003e\n\u003cli\u003eDo not use the syringe if the contents show signs of separation or a cloudy appearance.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise: sterility cannot be guaranteed after reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSterilisation:\u003c\/b\u003e syringe contents by moist heat; needles by irradiation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack includes:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, 4 sterile needles of 32G ½\", instruction leaflet and a set of traceability labels.\u003c\/li\u003e\n\u003cli\u003eUsed needles must be disposed of in appropriate containers; never straighten a bent needle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e untreated epilepsy; tendency to hypertrophic scarring; known hypersensitivity to hyaluronic acid or to Gram-positive bacterial proteins (the HA is obtained from bacteria of the genus \u003ci\u003eStreptococcus\u003c\/i\u003e); hypersensitivity to lidocaine or to amide-type local anaesthetics; porphyria; pregnancy and breastfeeding; minors. Do not inject into areas with inflammatory or infectious skin processes (acne, herpes). Do not inject intravascularly. Do not overcorrect.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eIncompatibilities:\u003c\/b\u003e hyaluronic acid is incompatible with quaternary ammonium salts such as benzalkonium chloride; avoid all contact with these substances or with instruments treated with them. No interactions with other local anaesthetics are known.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions and individual assessment:\u003c\/b\u003e there are no clinical data on efficacy and tolerance in patients with autoimmune disease, immunodeficiency or immunosuppressive therapy, nor in patients with a history of severe or multiple allergies — the indication is assessed case by case and a prior skin test is recommended; in case of a history of anaphylactic shock, it is recommended not to inject. Patients with a history of streptococcal disease (recurrent pharyngitis, acute rheumatic fever) should undergo a prior skin test. Warn patients on anticoagulant or antiplatelet therapy of the increased risk of bleeding and bruising. Because of the presence of lidocaine, combination with drugs that reduce or inhibit hepatic metabolism (cimetidine, beta blockers) is not recommended, and caution is advised in patients with cardiac conduction disorders.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not use simultaneously\u003c\/b\u003e with laser, deep chemical peels or dermabrasion. With superficial peels, do not inject if the inflammatory reaction generated is significant.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e serious adverse events have been reported in association with intravascular injection of facial dermal fillers — temporary or permanent visual impairment, blindness, cerebral ischaemia or haemorrhage with stroke, skin necrosis and injury to underlying structures. Stop the injection immediately in the event of any visual change, sign of stroke, skin pallor or unusual pain.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use enclosed in the packaging before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of Juvéderm® VOLBELLA® with lidocaine (Allergan Aesthetics \/ AbbVie) and, where indicated, on FDA approval dossiers and peer-reviewed scientific literature. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"Allergan","offers":[{"title":"Default Title","offer_id":51007630639444,"sku":null,"price":208.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/juvederm_volbella_c0587dd2-84d1-4af1-82e4-73278f07d624.jpg?v=1747765024"},{"product_id":"juvederm-voluma","title":"Juvederm Voluma 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eJuvéderm® VOLUMA® with lidocaine is the reference filler from Allergan Aesthetics for volumetric restoration of the middle facial third. Its cross-linked hyaluronic acid gel with VYCROSS™ technology combines high projection capacity with predictable tissue integration and a documented duration of up to 24 months in clinical study.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 20 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 × 27G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e up to 24 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 20 mg\/ml, cross-linking agent BDDE.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride monohydrate:\u003c\/b\u003e 3 mg\/ml, to reduce discomfort during injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer\u003c\/b\u003e pH 7.2 q.s. to 1 ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVYCROSS™ technology:\u003c\/b\u003e a combination of low- and high-molecular-weight hyaluronic acid. The greater cross-linking efficiency allows a lower total HA concentration while maintaining duration, with a gel of homogeneous texture and lower water uptake, which translates into reduced post-treatment swelling.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRheological profile:\u003c\/b\u003e G' of approximately 260–380 Pa depending on methodology (data from independent literature; Allergan does not publish official rheological values). High projection capacity with relatively low cohesivity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable implant indicated for the restoration of facial volume in patients aged 18 years and over.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCheekbones and malar region\u003c\/li\u003e\n\u003cli\u003eZygomatic region and projection of the middle third\u003c\/li\u003e\n\u003cli\u003eChin and definition of the facial contour\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eIt must not be injected\u003c\/b\u003e into the periorbital region (eyelid, tear trough, crow's feet), the glabella or the lips.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eManufacturer's dose limits:\u003c\/b\u003e maximum 2 ml per treatment area and session; maximum 20 ml of Allergan fillers per 60 kg of body weight per year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e deep dermis, subcutaneous tissue or supraperiosteal plane, depending on the area treated.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 4 units of 27G ½\", sterilised by irradiation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAspiration and retrograde injection\u003c\/b\u003e in accordance with standard clinical protocol to minimise vascular risk.\u003c\/li\u003e\n\u003cli\u003eNever inject intravascularly. Do not apply in areas with permanent implants.\u003c\/li\u003e\n\u003cli\u003eDo not combine in the same session with laser, deep peeling or dermabrasion.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e 96 % responders at 8 weeks and 81.7 % at 78 weeks (Callan P. et al., \u003ci\u003eClin Cosmet Investig Dermatol\u003c\/i\u003e 2013;6:81–9). FDA pivotal study: 67.1 % responders at 24 months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAllergan Aesthetics \/ AbbVie — Annecy, France\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive ingredient\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 20 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine HCl 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linking agent\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eVYCROSS™\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.2 (phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 × 27G ½\"\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked class III medical device (MDR 2017\/745)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated on the packaging.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack includes:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, 4 needles 27G ½\", instructions for use and traceability labels for the patient record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e pregnancy and breastfeeding; uncontrolled epilepsy; tendency to hypertrophic or keloid scarring; known allergy to hyaluronic acid or to Gram-positive bacterial proteins; allergy to lidocaine or to amide-type local anaesthetics; porphyria; active skin inflammation or infection in the area (acne, herpes); minors.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCaution and individual assessment:\u003c\/b\u003e autoimmune disease or immunosuppression; history of rheumatic fever or streptococcal infection; heart disease; severe or multiple allergies (previous anaphylaxis contraindicates treatment); anticoagulant or antiplatelet therapy; treatment with cimetidine or beta blockers because of the lidocaine.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use enclosed in the packaging before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (Juvéderm VOLUMA instructions for use, Allergan Aesthetics\/AbbVie) and on peer-reviewed scientific literature. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"Allergan","offers":[{"title":"Default Title","offer_id":51007631851860,"sku":null,"price":208.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/juvederm_voluma.jpg?v=1747764980"},{"product_id":"radiesse-lidocaina","title":"Radiesse Lidocaine 1x1.5ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eRADIESSE® (+) Lidocaine is the version of Merz Aesthetics' injectable calcium hydroxyapatite implant pre-mixed with 0.3 % lidocaine. It is not a hyaluronic acid filler: its CaHA microspheres of 25–45 µm — 30 % v\/v of the product — remain at the injection site while the carrier gel dissipates in vivo and is replaced by soft tissue growth. Unlike the version without lidocaine, it includes the jawline and marionette lines among the indications on its data sheet.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eActive substance\u003c\/b\u003e CaHA 25–45 µm\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRatio\u003c\/b\u003e 30 % CaHA \/ 70 % gel (v\/v)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 0.3 % HCl\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.5 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 27G thin wall\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eSterile, pyrogen-free, latex-free, semi-solid and cohesive implant: CaHA particles suspended in a carrier gel of sodium carboxymethylcellulose with glycerine and lidocaine hydrochloride at 0.3 % (w\/v), buffered with sodium phosphate salts.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eCaHA particles (25–45 µm)\u003c\/th\u003e\u003ctd\u003e30 % (v\/v) — 55.6–56.5 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCarrier gel\u003c\/th\u003e\u003ctd\u003e70 % (v\/v)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterile water for injection\u003c\/th\u003e\u003ctd\u003e35.4–36.2 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eGlycerine\u003c\/th\u003e\u003ctd\u003e6.3–6.5 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNaCMC\u003c\/th\u003e\u003ctd\u003e1.06–1.36 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLidocaine HCl monohydrate\u003c\/th\u003e\u003ctd\u003e0.22–0.23 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePhosphates\u003c\/th\u003e\u003ctd\u003e0.30–0.31 % (w\/w)\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eMechanism:\u003c\/b\u003e the carrier gel dissipates in vivo and is replaced by soft tissue growth; the calcium hydroxyapatite particles remain at the injection site. The result is a long-lasting, though not permanent, restoration and augmentation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlacement profile:\u003c\/b\u003e the highly viscoelastic CaHA is suitable for supraperiosteal, subdermal and deep dermal placement, with a considerable volumising effect.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRadiopacity:\u003c\/b\u003e the CaHA particles are radiopaque and visible on computed tomography. The patient should report their presence before any imaging examination.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable implant intended for the augmentation of dermal and deep subdermal soft tissue in adults.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eNasolabial folds\u003c\/th\u003e\u003ctd\u003eAt least 6–7 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCheek augmentation\u003c\/th\u003e\u003ctd\u003eAt least 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eMarionette lines\u003c\/th\u003e\u003ctd\u003eAt least 6–7 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eJawline\u003c\/th\u003e\u003ctd\u003eAt least 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHand augmentation (dorsum)\u003c\/th\u003e\u003ctd\u003eAt least 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eDurations documented by the manufacturer on the basis of clinical data.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eIt is not indicated\u003c\/b\u003e for the correction of glabellar folds or the area of the nose: a higher incidence of localised necrosis has been associated with injection in these areas. The manufacturer further states that the safety and efficacy of the product \u003cb\u003ein the lips\u003c\/b\u003e have not been established, and that cases of nodules have been published following its injection into the lips.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e subdermal and deep dermal; supraperiosteal according to the indication. Introduce the needle with the bevel facing downwards, at an angle of approximately 30° to the skin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e slow, continuous and uniform pressure on the plunger while withdrawing the needle, leaving a fine thread of material completely surrounded by soft tissue, without globular deposits. The threads are applied in parallel and may be cross-hatched in layers over a deeper plane for structural support.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCorrection factor 1:1. Do not overcorrect\u003c\/b\u003e — the volume of the soft tissue increases over several weeks.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaximum annual dose:\u003c\/b\u003e 10 ml for facial and hand indications, adaptable according to indication, tissue, age, injection depth and technique.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHands:\u003c\/b\u003e advance between the subcutaneous layer and the superficial fascia using a skin tenting technique; boluses of 0.2–0.5 ml, not exceeding 0.5 ml per bolus. Aspirate before injecting each bolus.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eJawline:\u003c\/b\u003e the safety and efficacy of cannula use for deep injection (subdermal and\/or supraperiosteal) in this indication have only been evaluated with a 25G cannula.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine:\u003c\/b\u003e in healthy adults, the maximum total recommended dose of lidocaine HCl without epinephrine should not exceed 300 mg (or 4.5 mg\/kg) per session, taking into account any other local anaesthetic administered in the same procedure.\u003c\/li\u003e\n\u003cli\u003eIf significant resistance is felt when pushing the plunger, move the needle slightly, change position or replace the needle or the syringe. Massage the treated area to achieve a uniform distribution.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMerz North America, Inc., Franksville, WI, USA\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEU representative\u003c\/th\u003e\u003ctd\u003eMerz Aesthetics GmbH, Eckenheimer Landstraße 100, 60318 Frankfurt am Main, Germany\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eSynthetic calcium hydroxyapatite (CaHA), particles of 25–45 µm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCarrier gel\u003c\/th\u003e\u003ctd\u003eSterile water for injection, glycerine and sodium carboxymethylcellulose, buffered with sodium phosphate salts\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 0.3 % (w\/v)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 1.5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 Terumo K-Pack II thin-wall 27G needles\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eSteam with parametric release cycle, SAL ≥ 10⁻⁶\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device; product without an intended medical purpose\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e inside its wrapping, at a controlled room temperature between \u003cb\u003e15 °C and 25 °C\u003c\/b\u003e. Keep dry and away from sunlight.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date printed on the product labels.\u003c\/li\u003e\n\u003cli\u003eDo not use if the pack, the pouch or the syringe is damaged, or if the cap or the plunger is not intact.\u003c\/li\u003e\n\u003cli\u003eSingle-use product, for one person and one treatment only. Do not re-sterilise or reuse.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.5 ml of RADIESSE® (+) Lidocaine and 2 Terumo K-Pack II thin-wall 27G needles.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e chronic and\/or acute inflammation or infection in the area to be treated; severe allergies manifested by a history of anaphylaxis or the presence of multiple severe allergies; known hypersensitivity to any of the components; \u003cb\u003eknown hypersensitivity to lidocaine or to amide-type anaesthetics\u003c\/b\u003e; tendency to develop inflammatory skin conditions, hypertrophic scars or keloids; presence of foreign bodies such as liquid silicone or other particulate materials; areas without healthy, well-vascularised tissue; systemic disorders causing poor wound healing; bleeding disorders; patients under 18 years of age; pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not apply\u003c\/b\u003e in the epidermis or the superficial dermis (risk of fistulas, infection, lumps, nodules and induration). \u003cb\u003eNot indicated\u003c\/b\u003e in glabellar folds or the nasal area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e introduction of the implant into the vascular system can cause embolisation or thrombosis, vascular occlusion, ischaemia or infarction; rare but serious cases of temporary or permanent loss of vision, blindness, cerebral ischaemia or haemorrhage resulting in stroke, and skin necrosis have been reported. Stop the injection immediately if changes in vision, signs of stroke, skin blanching or unusual pain occur. Do not inject into organs or structures that may be damaged by a space-occupying implant. Do not overcorrect. It must not be injected into people taking aspirin or other medicines that may impair wound healing. Injection into the dorsum of the hand may cause intense swelling; take extreme care to avoid vessels and tendons.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eLidocaine:\u003c\/b\u003e may be associated with numbness (hypoaesthesia) and with allergic reactions. An overdose usually gives rise to signs of central nervous system or cardiovascular toxicity; if signs of toxicity occur, stop administration and seek urgent medical assistance.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of the RADIESSE® (+) Lidocaine injectable implant (Merz North America, Inc. \/ Merz Aesthetics GmbH, Spanish version, January 2025) and on the US instructions for use of the product with regard to labial use. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Merz Aesthetics","offers":[{"title":"Default Title","offer_id":51007633031508,"sku":null,"price":160.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/radiesse_lidocaine.jpg?v=1747685181"},{"product_id":"restylane-defyne","title":"Restylane Defyne 1x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eRestylane Defyne is the firmest gel in Galderma's OBT™ family: with an elastic modulus of 271 Pa and a deformability of 761 %, it supports deep folds without losing the flexibility that allows facial movement. It is formulated for severe wrinkles and folds \u0026mdash; nasolabial fold and marionette lines \u0026mdash; where a NASHA gel would be too rigid.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 20 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnology\u003c\/b\u003e OBT™ \/ XpresHAn™\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 27G ½\u0026quot; UTW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 20 mg\/ml, of non-animal origin, cross-linked with BDDE and suspended in phosphate buffer solution at pH 7.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml, to reduce discomfort during injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOBT™ technology (Optimal Balance Technology):\u003c\/b\u003e unlike NASHA gels, which are particulate and minimally cross-linked, OBT modulates the degree of cross-linking to obtain a continuous, soft and deformable gel. Defyne is the variant with the highest degree of cross-linking within OBT.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRheological profile:\u003c\/b\u003e G\u0026prime; 271 Pa at 0.1 Hz and deformability (xStrain) of 761 %. It is the highest firmness value and the lowest flexibility value of the OBT family: maximum support within a gel that still follows facial expression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the range: NASHA and OBT\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe entire Restylane range is built on two different gel technologies. Choosing between them is the first clinical decision of the treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eNASHA®\u003c\/b\u003e (\u003ci\u003eNon-Animal Stabilized Hyaluronic Acid\u003c\/i\u003e): firm, particulate gels that retain the long hyaluronic acid chains with minimal cross-linking. High resistance and very low tolerance to deformation: projection, definition and structural support in areas that must hold their shape.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eOBT™\u003c\/b\u003e (\u003ci\u003eOptimal Balance Technology\u003c\/i\u003e, called \u003ci\u003eXpresHAn Technology™\u003c\/i\u003e in the US market): soft, flexible gels with a variable degree of cross-linking. Low to intermediate resistance and high tolerance to deformation: the gel follows the movement of the tissue, so it is intended for dynamic and expressive areas.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eNASHA — firmness and projection\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 416\u0026ndash;799 Pa \u0026middot; deformability 7\u0026ndash;19 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane \/ Classyc Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 701 Pa \u0026middot; 7 % \u0026mdash; wrinkles in the mid dermis, lips\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Lyft Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 799 Pa \u0026middot; 17 % \u0026mdash; cheekbones, mid third of the face, dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Eyelight\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026mdash; infraorbital hollowing, supraperiosteal plane\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Skinboosters Vital \/ Vital Light\u003c\/th\u003e\u003ctd\u003eHA 20 and 12 mg\/ml \u0026mdash; skin quality and hydration, without volumetric purpose\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOBT \/ XpresHAn — flexibility and expression\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 70\u0026ndash;271 Pa \u0026middot; deformability 761\u0026ndash;1,442 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Refyne\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 70 Pa \u0026middot; 1,442 % \u0026mdash; moderate wrinkles and folds\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Kysse\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 160 Pa \u0026middot; 908 % \u0026mdash; lips, submucosal plane\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Volyme\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 171 Pa \u0026middot; 930 % \u0026mdash; malar volume, supraperiosteal or subcutaneous\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Defyne\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 271 Pa \u0026middot; 761 % \u0026mdash; severe wrinkles and folds\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe G\u0026prime; (0.1 Hz) and deformability (xStrain) values come from peer-reviewed literature (\u003ci\u003eJ Drugs Dermatol\u003c\/i\u003e 2024;23(12):1332\u0026ndash;1338). Galderma does not publish official rheological values.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjection into the mid to deep dermis for the correction of severe facial wrinkles and folds.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNasolabial fold\u003c\/li\u003e\n\u003cli\u003eMarionette lines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCompared with Restylane Refyne (G\u0026prime; 70 Pa), indicated for moderate wrinkles, Defyne is reserved for deeper defects that require more structural support.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e mid to deep dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 2 units of 27G ½\u0026quot; ultra-thin wall (UTW).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e linear retrograde threading, serial puncture or a combination of both, with low, constant injection pressure.\u003c\/li\u003e\n\u003cli\u003ePrior aspiration in accordance with standard clinical protocol to minimise vascular risk.\u003c\/li\u003e\n\u003cli\u003eDo not combine in the same session with laser treatment, deep peeling or dermabrasion.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e in the pivotal study submitted to the FDA, 77.1 % of subjects maintained an improvement at 6 months and 69.7 % at one year, measured with the WSRS (\u003ci\u003eWrinkle Severity Rating Scale\u003c\/i\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eQ-Med AB (Galderma) \u0026mdash; Seminariegatan 21, SE-752 28 Uppsala, Sweden\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 20 mg\/ml, non-animal origin\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eOBT™ (XpresHAn Technology™)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVehicle \/ pH\u003c\/th\u003e\u003ctd\u003ePhosphate buffer solution, pH 7\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRheology\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 271 Pa \u0026middot; deformability 761 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 27G ½\u0026quot; ultra-thin wall\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eMid to deep dermis\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe contents) \/ irradiation (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device (MDR 2017\/745)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e up to 25 °C. Protect from freezing and from sunlight.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.0 ml, 2 needles 27G ½\u0026quot; UTW, instructions for use and traceability labels for the patient record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications (Galderma instructions for use):\u003c\/b\u003e known hypersensitivity to streptococcal proteins or to any component of the product; history of severe allergies or of an anaphylactic reaction; hypersensitivity to lidocaine or to amide-type local anaesthetics; porphyria; active skin inflammation or infection in the area to be treated.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions and individual assessment:\u003c\/b\u003e coagulation disorders or anticoagulant or antiplatelet therapy (increased risk of haematoma and bleeding at the puncture site); history of hypertrophic or keloid scarring; autoimmune disease; presence of permanent implants in the area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e do not inject intravascularly or intramuscularly. Intravascular injection can cause embolisation, vascular occlusion, ischaemia, skin necrosis, visual disturbance, blindness or stroke. Aspiration before injecting and low, constant injection pressure are recommended. Do not mix the gel with other products.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (Restylane® Defyne™ instructions for use, Q-Med AB \/ Galderma). This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51007633293652,"sku":null,"price":86.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/restylane_defyne_9ad0a8db-16e9-4bf7-88f0-1b2ddf7839c5.jpg?v=1775491905"},{"product_id":"restylane-kysse","title":"Restylane Kysse 1x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eRestylane Kysse is Galderma's OBT™ gel designed specifically for the lip. Its rheological balance \u0026mdash; G\u0026prime; 160 Pa with a deformability of 908 % \u0026mdash; aims to provide volume and definition while maintaining lip mobility during speech and smiling. It is applied in the submucosal plane and also covers the upper perioral rhytides.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 20 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnology\u003c\/b\u003e OBT™ \/ XpresHAn™\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\u0026quot; UTW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 20 mg\/ml, of non-animal origin, cross-linked with BDDE (1,4-butanediol diglycidyl ether) in phosphate buffer solution at pH 7.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOBT™ technology:\u003c\/b\u003e continuous, flexible, non-particulate gel. Kysse occupies the second-lowest firmness step of the OBT family, ahead only of Refyne.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRheological profile:\u003c\/b\u003e G\u0026prime; 160 Pa at 0.1 Hz and deformability (xStrain) of 908 %. The combination of low firmness and very high flexibility is what defines its labial use: enough support for volume, without perceptible stiffness during facial expression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the range: NASHA and OBT\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe entire Restylane range is built on two different gel technologies. Choosing between them is the first clinical decision of the treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eNASHA®\u003c\/b\u003e (\u003ci\u003eNon-Animal Stabilized Hyaluronic Acid\u003c\/i\u003e): firm, particulate gels that retain the long hyaluronic acid chains with minimal cross-linking. High resistance and very low tolerance to deformation: projection, definition and structural support in areas that must hold their shape.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eOBT™\u003c\/b\u003e (\u003ci\u003eOptimal Balance Technology\u003c\/i\u003e, called \u003ci\u003eXpresHAn Technology™\u003c\/i\u003e in the US market): soft, flexible gels with a variable degree of cross-linking. Low to intermediate resistance and high tolerance to deformation: the gel follows the movement of the tissue, so it is intended for dynamic and expressive areas.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eNASHA — firmness and projection\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 416\u0026ndash;799 Pa \u0026middot; deformability 7\u0026ndash;19 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane \/ Classyc Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 701 Pa \u0026middot; 7 % \u0026mdash; wrinkles in the mid dermis, lips\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Lyft Lidocaine\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 799 Pa \u0026middot; 17 % \u0026mdash; cheekbones, mid third of the face, dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Eyelight\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026mdash; infraorbital hollowing, supraperiosteal plane\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Skinboosters Vital \/ Vital Light\u003c\/th\u003e\u003ctd\u003eHA 20 and 12 mg\/ml \u0026mdash; skin quality and hydration, without volumetric purpose\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOBT \/ XpresHAn — flexibility and expression\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 70\u0026ndash;271 Pa \u0026middot; deformability 761\u0026ndash;1,442 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Refyne\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 70 Pa \u0026middot; 1,442 % \u0026mdash; moderate wrinkles and folds\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Kysse\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 160 Pa \u0026middot; 908 % \u0026mdash; lips, submucosal plane\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Volyme\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 171 Pa \u0026middot; 930 % \u0026mdash; malar volume, supraperiosteal or subcutaneous\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRestylane Defyne\u003c\/th\u003e\u003ctd\u003eHA 20 mg\/ml \u0026middot; G\u0026prime; 271 Pa \u0026middot; 761 % \u0026mdash; severe wrinkles and folds\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe G\u0026prime; (0.1 Hz) and deformability (xStrain) values come from peer-reviewed literature (\u003ci\u003eJ Drugs Dermatol\u003c\/i\u003e 2024;23(12):1332\u0026ndash;1338). Galderma does not publish official rheological values.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eTo restore or increase lip volume and to correct the upper perioral rhytides.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLip body \u0026mdash; volume augmentation\u003c\/li\u003e\n\u003cli\u003eVermilion border and philtral columns \u0026mdash; definition\u003c\/li\u003e\n\u003cli\u003eUpper perioral rhytides (barcode lines)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eInjection that is too superficial can produce contour irregularities, palpable nodules or bluish discoloration (Tyndall effect).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e submucosal in the lip body; from the mid dermis to the subcutaneous plane in the perioral rhytides and the philtral columns.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 2 units of 30G ½\u0026quot; ultra-thin wall. Blunt cannulas of 25\u0026ndash;27G may be used as an alternative.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e linear retrograde threading or serial puncture, with low, constant pressure; light massage to shape after the deposit.\u003c\/li\u003e\n\u003cli\u003ePrior aspiration in accordance with standard clinical protocol; the perioral region is an area of significant vascular risk.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDocumented duration:\u003c\/b\u003e in the pivotal study, 60 % of subjects maintained the improvement in lip volume at week 48; the improvement in perioral rhytides was maintained up to week 48 in the majority of subjects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eQ-Med AB (Galderma) \u0026mdash; Seminariegatan 21, SE-752 28 Uppsala, Sweden\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 20 mg\/ml, non-animal origin\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eOBT™ (XpresHAn Technology™)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVehicle \/ pH\u003c\/th\u003e\u003ctd\u003ePhosphate buffer solution, pH 7\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRheology\u003c\/th\u003e\u003ctd\u003eG\u0026prime; 160 Pa \u0026middot; deformability 908 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\u0026quot; ultra-thin wall (alternative: 25\u0026ndash;27G blunt cannula)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eSubmucosal (lip); mid dermis to subcutaneous (perioral)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe contents) \/ ethylene oxide (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device (MDR 2017\/745)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e up to 25 °C. Protect from freezing and from sunlight.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.0 ml, 2 needles 30G ½\u0026quot; UTW, instructions for use and traceability labels for the patient record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications (Galderma instructions for use):\u003c\/b\u003e known hypersensitivity to streptococcal proteins or to any component of the product; history of severe allergies or of an anaphylactic reaction; hypersensitivity to lidocaine or to amide-type local anaesthetics; porphyria; active skin inflammation or infection in the area to be treated.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions and individual assessment:\u003c\/b\u003e coagulation disorders or anticoagulant or antiplatelet therapy (increased risk of haematoma and bleeding at the puncture site); history of hypertrophic or keloid scarring; autoimmune disease; presence of permanent implants in the area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e do not inject intravascularly or intramuscularly. Intravascular injection can cause embolisation, vascular occlusion, ischaemia, skin necrosis, visual disturbance, blindness or stroke. Aspiration before injecting and low, constant injection pressure are recommended. Do not mix the gel with other products.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (Restylane® Kysse™ instructions for use, Q-Med AB \/ Galderma). This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51007633523028,"sku":null,"price":82.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/Restylane_Kysse_6da8ad13-e84b-4618-9f54-f4c54c329e64.jpg?v=1775491905"},{"product_id":"11980","title":"Stylage L Lidocaine 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eSTYLAGE\u0026reg; L Lidocaine is the deep dermis filler of the Laboratoires VIVACY range: 24 mg of BDDE cross-linked hyaluronic acid per gram of gel, with 3 mg of lidocaine hydrochloride and mannitol as an antioxidant. Its indication according to the instructions for use is limited to filling cutaneous depressions of the face by injection into the deep dermis; the manufacturer expressly excludes it from superficial wrinkles, thin skin and the lips.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 24 mg\/g (BDDE)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/g\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes \u0026times; 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 sterile single-use\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e Deep dermis\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid (BDDE):\u003c\/b\u003e 24 mg.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg, intended to reduce the pain associated with injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer and mannitol,\u003c\/b\u003e pH 7.2, q.s. to 1 g of gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMannitol (antioxidant):\u003c\/b\u003e incorporated into the formulation as an antioxidant agent. According to VIVACY's technical documentation, it protects the hyaluronic acid gel against the damage caused by the free radicals (oxidative stress) generated during the injection process, thereby slowing the degradation of the hyaluronic acid. It is the differentiating element of the STYLAGE range compared with conventional HA fillers.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eIPN-Like technology (InterPenetrated Networks):\u003c\/b\u003e VIVACY's patented cross-linking technology. It preserves the partial independence of the interpenetrated hyaluronic acid networks while increasing the density of chemical nodes. The manufacturer associates it with the optimisation of the gel's rheology — in particular the viscosity, to ensure injectability — and with the cohesivity and monophasic character of the gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e BDDE. Hyaluronic acid of non-animal origin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBi-SOFT\u0026reg; syringe:\u003c\/b\u003e patented bi-material injection system (polycarbonate and thermoplastic elastomer with a soft-touch surface), with oversized plunger and finger flanges and an optimised centre of gravity. It is a property of the syringe, not of the gel: it aims to reduce the perceived injection force and improve control of the deposit.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSterile, non-pyrogenic gel,\u003c\/b\u003e of physiological pH and osmolarity, packaged in a pre-filled syringe and sterilised by autoclave (moist heat). The needles are sterilised by irradiation or ethylene oxide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the variants of the STYLAGE\u0026reg; range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe range is graded by hyaluronic acid concentration and degree of cross-linking, which determines\nthe consistency of the gel and, with it, the injection plane and the indication. The concentrations\nare taken from the manufacturer's instructions for use and are expressed per gram of gel (q.s. to 1 g).\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eS\u0026nbsp;\u0026mdash; 16 mg\/g\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis. Cutaneous depressions of the face; lip definition by injection into the mucosa. 0.8 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eM\u0026nbsp;\u0026mdash; 20 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Cutaneous depressions; lip definition and\/or volume augmentation; restoration of volume on the dorsum of the hand by the subcutaneous route\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eL\u0026nbsp;\u0026mdash; 24 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis. Cutaneous depressions of the face. Not indicated for superficial wrinkles or for thin skin, lips or areas with an exposed vascular network\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXL\u0026nbsp;\u0026mdash; 26 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. Restoration or augmentation of facial volumes. It is the highest concentration in the range\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXXL\u0026nbsp;\u0026mdash; 21 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. High-viscosity volumising; the only one in the range whose pack includes a cannula\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSpecial Lips\u0026nbsp;\u0026mdash; 18.5 mg\/g\u003c\/th\u003e\u003ctd\u003eLabial mucosa. Redefinition and\/or augmentation of lip volume\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHydroMax\u0026nbsp;\u0026mdash; 12.5 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Skin hydration and elasticity. The only one in the range formulated with sorbitol instead of mannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe concentration of XXL is lower than that of XL: the range is not a linear ascending scale. XL and XXL\nshare a volumising indication and injection plane, and differ in the rheological behaviour\nof the gel \u0026mdash; the manufacturer positions XXL as a high-viscosity volumiser.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable hyaluronic acid gel intended to fill cutaneous depressions of the face by injection into the deep dermis. The lidocaine hydrochloride is intended to reduce the pain associated with injection.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eRestrictions specific to the L variant\u003c\/b\u003e according to the instructions for use \u0026mdash; it must not be used:\u003c\/p\u003e\u003cul\u003e\u003cli\u003eFor injections intended to treat superficial wrinkles.\u003c\/li\u003e\u003cli\u003eIn areas of thin skin: forehead, periorbital region (eyelids, tear troughs, crow's feet).\u003c\/li\u003e\u003cli\u003eIn areas with an exposed vascular network, such as the glabellar region.\u003c\/li\u003e\u003cli\u003eIn the lips.\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003e\u003cb\u003eNote on the scope of the indication:\u003c\/b\u003e the restoration of volume on the dorsum of the hand appears in the instructions for use for STYLAGE\u0026reg; L without lidocaine, but not for the version with lidocaine. The restoration or augmentation of facial volumes corresponds to the XL and XXL variants, not to L.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e deep dermis of the face.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e retrograde linear injection, multi-puncture technique or a combination of both.\u003c\/li\u003e\n\u003cli\u003eOnly the needles supplied with the product should be used: the combination of both devices has been validated by the manufacturer. Screw the needle firmly onto the Luer-Lock cone.\u003c\/li\u003e\n\u003cli\u003eThe use of sterile CE-marked blunt-tip cannulas is possible. In that case the practitioner must select the appropriate gauge and length and scrupulously observe aseptic conditions, in particular the pre-hole.\u003c\/li\u003e\n\u003cli\u003eInject slowly to avoid overcorrection. If the injection is too deep, the efficacy of the correction is reduced; if it is too superficial, skin discolouration, small indurations or an irregular correction may appear.\u003c\/li\u003e\n\u003cli\u003eIt is recommended not to inject more than 20 ml of cross-linked hyaluronic acid per person per year (all ranges combined).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSessions:\u003c\/b\u003e depending on the characteristics of the area, of the patient and of the depth of injection, one or two sessions are required for optimal treatment. Regular touch-up sessions allow the correction to be maintained.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAfter injection:\u003c\/b\u003e do not apply cold and massage the treated area thoroughly to optimise the uniformity of the correction.\u003c\/li\u003e\n\u003cli\u003eDo not inject into areas previously corrected with implants outside the STYLAGE\u0026reg; range: no clinical data are available for those cases. Do not mix with another product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eLaboratoires VIVACY, Archamps Technopole, 74160 Archamps (France)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 24 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAntioxidant\u003c\/th\u003e\u003ctd\u003eMannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eIPN-Like (cross-linking) \u0026middot; Bi-SOFT\u0026reg; syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.2 (phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 sterile single-use needles (gauge not specified in the instructions for use)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eDeep dermis\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation or ethylene oxide (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking in accordance with Directive 93\/42\/EEC; notified body 0344. According to the instructions for use, STYLAGE\u0026reg; L Lidocaine obtained CE marking in 2012\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTraceability\u003c\/th\u003e\u003ctd\u003eVIVACY remote authentication system with RFID technology\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e in its original packaging between 2 \u0026deg;C and 25 \u0026deg;C, protected from freezing and from light. Failure to comply with the storage conditions may affect the performance of the product.\u003c\/li\u003e\n\u003cli\u003eIf it has been kept in a refrigerator, allow the product to reach room temperature before injection.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging and on the syringe. Do not use if the packaging is damaged.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise, even if the implant has not been injected. Inject immediately after opening.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, 4 sterile single-use needles, instructions for use and labels with the batch number \u0026mdash; one for the patient and one for the medical record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eMust not be used:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ein combination with a peel, a laser treatment or dermabrasion (the practitioner decides the waiting period required after these treatments)\u003c\/li\u003e\n\u003cli\u003ein patients with a tendency to develop hypertrophic scars\u003c\/li\u003e\n\u003cli\u003ein patients with known hypersensitivity to any of the components\u003c\/li\u003e\n\u003cli\u003ein pregnant or breastfeeding women, or in children\u003c\/li\u003e\n\u003cli\u003ein areas or in the vicinity of areas with inflammatory or infectious skin problems (acne, herpes, etc.)\u003c\/li\u003e\n\u003cli\u003efor the treatment of superficial wrinkles\u003c\/li\u003e\n\u003cli\u003ein areas of thin skin (forehead, periorbital region including eyelids, tear troughs and crow's feet), in areas with an exposed vascular network (glabellar region) or in the lips\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eIn addition, because of its lidocaine content,\u003c\/b\u003e it must not be used in patients with known hypersensitivity to amide-type local anaesthetics or in patients with porphyria. Combination with certain medicinal products that reduce or inhibit hepatic metabolism is not advised. Lidocaine hydrochloride may induce a positive reaction in anti-doping tests.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions for use:\u003c\/b\u003e it is strongly recommended to obtain the patient's informed consent. In patients with a history of herpes, the punctures may trigger a new outbreak. In patients with declared autoimmune disease or a history thereof, the practitioner must decide on a case-by-case basis, propose a prior double test and not inject if the disease is progressive. Patients with a history of streptococcal disease (recurrent tonsillitis, rheumatic fever) must undergo a prior double test; in the case of rheumatic fever with cardiac involvement, injection is not recommended. In the case of a haemostatic disorder or anticoagulant therapy, the risk of haematoma is increased. The intake of aspirin, NSAIDs, antiplatelet agents, anticoagulants or vitamin C should be avoided in the week before injection.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e do not inject into blood vessels. Accidental intravascular injection may cause vascular occlusion with rare but serious complications — visual disturbances, blindness, necrosis of the skin and\/or of the underlying tissues — depending on the area injected. Do not inject into nerves: accidental nerve injury may cause transient paraesthesia.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of Laboratoires VIVACY (OPDC340 v4) and on the manufacturer's technical documentation. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Vivacy","offers":[{"title":"Default Title","offer_id":51007635226964,"sku":null,"price":124.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/Stylage-Bi-Soft-L-Lidocaine_600x_1b07b14a-82fa-43a2-8052-06668ddbc62e.webp?v=1735927899"},{"product_id":"11982","title":"Stylage M Lidocaine 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eSTYLAGE\u0026reg; M Lidocaine is the intermediate-consistency filler of the Laboratoires VIVACY range: 20 mg of BDDE cross-linked hyaluronic acid per gram of gel, with 3 mg of lidocaine hydrochloride and mannitol as an antioxidant. It is injected into the mid to deep dermis for cutaneous depressions of the face and into the labial mucosa for lip definition and\/or volume augmentation.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 20 mg\/g (BDDE)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/g\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes \u0026times; 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 sterile single-use\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e Mid to deep dermis\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid (BDDE):\u003c\/b\u003e 20 mg.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg, intended to reduce the pain associated with injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer and mannitol,\u003c\/b\u003e pH 7.2, q.s. to 1 g of gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMannitol (antioxidant):\u003c\/b\u003e incorporated into the formulation as an antioxidant agent. According to VIVACY's technical documentation, it protects the hyaluronic acid gel against the damage caused by the free radicals (oxidative stress) generated during the injection process, thereby slowing the degradation of the hyaluronic acid. It is the differentiating element of the STYLAGE range compared with conventional HA fillers.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eIPN-Like technology (InterPenetrated Networks):\u003c\/b\u003e VIVACY's patented cross-linking technology. It preserves the partial independence of the interpenetrated hyaluronic acid networks while increasing the density of chemical nodes. The manufacturer associates it with the optimisation of the gel's rheology — in particular the viscosity, to ensure injectability — and with the cohesivity and monophasic character of the gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e BDDE. Hyaluronic acid of non-animal origin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBi-SOFT\u0026reg; syringe:\u003c\/b\u003e patented bi-material injection system (polycarbonate and thermoplastic elastomer with a soft-touch surface), with oversized plunger and finger flanges and an optimised centre of gravity. It is a property of the syringe, not of the gel: it aims to reduce the perceived injection force and improve control of the deposit.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSterile, non-pyrogenic gel,\u003c\/b\u003e of physiological pH and osmolarity, packaged in a pre-filled syringe and sterilised by autoclave (moist heat). The needles are sterilised by irradiation or ethylene oxide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the variants of the STYLAGE\u0026reg; range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe range is graded by hyaluronic acid concentration and degree of cross-linking, which determines\nthe consistency of the gel and, with it, the injection plane and the indication. The concentrations\nare taken from the manufacturer's instructions for use and are expressed per gram of gel (q.s. to 1 g).\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eS\u0026nbsp;\u0026mdash; 16 mg\/g\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis. Cutaneous depressions of the face; lip definition by injection into the mucosa. 0.8 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eM\u0026nbsp;\u0026mdash; 20 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Cutaneous depressions; lip definition and\/or volume augmentation; restoration of volume on the dorsum of the hand by the subcutaneous route\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eL\u0026nbsp;\u0026mdash; 24 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis. Cutaneous depressions of the face. Not indicated for superficial wrinkles or for thin skin, lips or areas with an exposed vascular network\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXL\u0026nbsp;\u0026mdash; 26 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. Restoration or augmentation of facial volumes. It is the highest concentration in the range\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXXL\u0026nbsp;\u0026mdash; 21 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. High-viscosity volumising; the only one in the range whose pack includes a cannula\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSpecial Lips\u0026nbsp;\u0026mdash; 18.5 mg\/g\u003c\/th\u003e\u003ctd\u003eLabial mucosa. Redefinition and\/or augmentation of lip volume\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHydroMax\u0026nbsp;\u0026mdash; 12.5 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Skin hydration and elasticity. The only one in the range formulated with sorbitol instead of mannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe concentration of XXL is lower than that of XL: the range is not a linear ascending scale. XL and XXL\nshare a volumising indication and injection plane, and differ in the rheological behaviour\nof the gel \u0026mdash; the manufacturer positions XXL as a high-viscosity volumiser.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable hyaluronic acid gel intended to fill cutaneous depressions of the face by injection into the dermis. STYLAGE\u0026reg; M Lidocaine is equally indicated for the definition and\/or augmentation of lip volume by injection into the labial mucosa. The lidocaine hydrochloride is intended to reduce the pain associated with injection.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eRelevant difference from STYLAGE\u0026reg; M without lidocaine:\u003c\/b\u003e the version without anaesthetic additionally covers the restoration of volume on the dorsum of the hand by the subcutaneous route. That indication does not appear in the instructions for use for the version with lidocaine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e mid to deep dermis of the face; labial mucosa for the treatment of the lips.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e retrograde linear injection, multi-puncture technique or a combination of both.\u003c\/li\u003e\n\u003cli\u003eOnly the needles supplied with the product should be used: the combination of both devices has been validated by the manufacturer. Screw the needle firmly onto the Luer-Lock cone.\u003c\/li\u003e\n\u003cli\u003eThe use of sterile CE-marked blunt-tip cannulas is possible. In that case the practitioner must select the appropriate gauge and length and scrupulously observe aseptic conditions, in particular the pre-hole.\u003c\/li\u003e\n\u003cli\u003eInject slowly to avoid overcorrection. If the injection is too deep, the efficacy of the correction is reduced; if it is too superficial, skin discolouration, small indurations or an irregular correction may appear.\u003c\/li\u003e\n\u003cli\u003eIt is recommended not to inject more than 20 ml of cross-linked hyaluronic acid per person per year (all ranges combined).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSessions:\u003c\/b\u003e depending on the characteristics of the area, of the patient and of the depth of injection, one or two sessions are required for optimal treatment. Regular touch-up sessions allow the correction to be maintained.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAfter injection:\u003c\/b\u003e do not apply cold and massage the treated area thoroughly to optimise the uniformity of the correction.\u003c\/li\u003e\n\u003cli\u003eAdvise the patient to use high-factor sun protection for the following two weeks, not to apply make-up within the next 12 hours and to avoid sources of intense heat (UV, sauna, hammam) or extreme cold until the post-injection oedema or erythema has resolved.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eLaboratoires VIVACY, Archamps Technopole, 74160 Archamps (France)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 20 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAntioxidant\u003c\/th\u003e\u003ctd\u003eMannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eIPN-Like (cross-linking) \u0026middot; Bi-SOFT\u0026reg; syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.2 (phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 sterile single-use needles (gauge not specified in the instructions for use)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eMid to deep dermis; labial mucosa\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation or ethylene oxide (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking in accordance with Directive 93\/42\/EEC; notified body 0344. According to the instructions for use, STYLAGE\u0026reg; M Lidocaine obtained CE marking in 2009\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTraceability\u003c\/th\u003e\u003ctd\u003eVIVACY remote authentication system with RFID technology\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e in its original packaging between 2 \u0026deg;C and 25 \u0026deg;C, protected from freezing and from light. Failure to comply with the storage conditions may affect the performance of the product.\u003c\/li\u003e\n\u003cli\u003eIf it has been kept in a refrigerator, allow the product to reach room temperature before injection.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging and on the syringe. Do not use if the packaging is damaged.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise, even if the implant has not been injected. Inject immediately after opening.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, 4 sterile single-use needles, instructions for use and labels with the batch number \u0026mdash; one for the patient and one for the medical record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eMust not be used:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ein combination with a peel, a laser treatment or dermabrasion (the practitioner decides the waiting period required after these treatments)\u003c\/li\u003e\n\u003cli\u003ein patients with a tendency to develop hypertrophic scars\u003c\/li\u003e\n\u003cli\u003ein patients with known hypersensitivity to any of the components\u003c\/li\u003e\n\u003cli\u003ein pregnant or breastfeeding women, or in children\u003c\/li\u003e\n\u003cli\u003ein areas or in the vicinity of areas with inflammatory or infectious skin problems (acne, herpes, etc.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eIn addition, because of its lidocaine content,\u003c\/b\u003e it must not be used in patients with known hypersensitivity to amide-type local anaesthetics or in patients with porphyria. Combination with certain medicinal products that reduce or inhibit hepatic metabolism is not advised. Lidocaine hydrochloride may induce a positive reaction in anti-doping tests.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions for use:\u003c\/b\u003e it is strongly recommended to obtain the patient's informed consent. In patients with a history of herpes, the punctures may trigger a new outbreak. In patients with declared autoimmune disease or a history thereof, the practitioner must decide on a case-by-case basis, propose a prior double test and not inject if the disease is progressive. Patients with a history of streptococcal disease (recurrent tonsillitis, rheumatic fever) must undergo a prior double test; in the case of rheumatic fever with cardiac involvement, injection is not recommended. In the case of a haemostatic disorder or anticoagulant therapy, the risk of haematoma is increased. The intake of aspirin, NSAIDs, antiplatelet agents, anticoagulants or vitamin C should be avoided in the week before injection.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e do not inject into blood vessels. Accidental intravascular injection may cause vascular occlusion with rare but serious complications — visual disturbances, blindness, necrosis of the skin and\/or of the underlying tissues — depending on the area injected. Do not inject into nerves: accidental nerve injury may cause transient paraesthesia.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of Laboratoires VIVACY (OPDC340 v4) and on the manufacturer's technical documentation. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Vivacy","offers":[{"title":"Default Title","offer_id":51007635423572,"sku":null,"price":112.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/Stylage-Bi-Soft-M-Lidocaine_600x_f47bc62c-0a87-450a-bd1a-a5a12530a863.webp?v=1735927899"},{"product_id":"11984","title":"Stylage S Lidocaine 2x0.8ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eSTYLAGE\u0026reg; S Lidocaine is the lowest-concentration filler in the Laboratoires VIVACY dermal filler range: 16 mg of BDDE cross-linked hyaluronic acid per gram of gel, with 3 mg of lidocaine hydrochloride. It is indicated for filling cutaneous depressions of the face by injection into the superficial to mid dermis and for lip definition by injection into the labial mucosa. Like the whole STYLAGE range, it incorporates mannitol as an antioxidant.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 16 mg\/g (BDDE)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/g\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes \u0026times; 0.8 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 sterile single-use\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e Superficial to mid dermis\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid (BDDE):\u003c\/b\u003e 16 mg.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg, intended to reduce the pain associated with injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhosphate buffer and mannitol,\u003c\/b\u003e pH 7.2, q.s. to 1 g of gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMannitol (antioxidant):\u003c\/b\u003e incorporated into the formulation as an antioxidant agent. According to VIVACY's technical documentation, it protects the hyaluronic acid gel against the damage caused by the free radicals (oxidative stress) generated during the injection process, thereby slowing the degradation of the hyaluronic acid. It is the differentiating element of the STYLAGE range compared with conventional HA fillers.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eIPN-Like technology (InterPenetrated Networks):\u003c\/b\u003e VIVACY's patented cross-linking technology. It preserves the partial independence of the interpenetrated hyaluronic acid networks while increasing the density of chemical nodes. The manufacturer associates it with the optimisation of the gel's rheology — in particular the viscosity, to ensure injectability — and with the cohesivity and monophasic character of the gel.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linker:\u003c\/b\u003e BDDE. Hyaluronic acid of non-animal origin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBi-SOFT\u0026reg; syringe:\u003c\/b\u003e patented bi-material injection system (polycarbonate and thermoplastic elastomer with a soft-touch surface), with oversized plunger and finger flanges and an optimised centre of gravity. It is a property of the syringe, not of the gel: it aims to reduce the perceived injection force and improve control of the deposit.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSterile, non-pyrogenic gel,\u003c\/b\u003e of physiological pH and osmolarity, packaged in a pre-filled syringe and sterilised by autoclave (moist heat). The needles are sterilised by irradiation or ethylene oxide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the variants of the STYLAGE\u0026reg; range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe range is graded by hyaluronic acid concentration and degree of cross-linking, which determines\nthe consistency of the gel and, with it, the injection plane and the indication. The concentrations\nare taken from the manufacturer's instructions for use and are expressed per gram of gel (q.s. to 1 g).\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eS\u0026nbsp;\u0026mdash; 16 mg\/g\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis. Cutaneous depressions of the face; lip definition by injection into the mucosa. 0.8 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eM\u0026nbsp;\u0026mdash; 20 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Cutaneous depressions; lip definition and\/or volume augmentation; restoration of volume on the dorsum of the hand by the subcutaneous route\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eL\u0026nbsp;\u0026mdash; 24 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis. Cutaneous depressions of the face. Not indicated for superficial wrinkles or for thin skin, lips or areas with an exposed vascular network\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXL\u0026nbsp;\u0026mdash; 26 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. Restoration or augmentation of facial volumes. It is the highest concentration in the range\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXXL\u0026nbsp;\u0026mdash; 21 mg\/g\u003c\/th\u003e\u003ctd\u003eDeep dermis or subcutaneous plane. High-viscosity volumising; the only one in the range whose pack includes a cannula\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSpecial Lips\u0026nbsp;\u0026mdash; 18.5 mg\/g\u003c\/th\u003e\u003ctd\u003eLabial mucosa. Redefinition and\/or augmentation of lip volume\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHydroMax\u0026nbsp;\u0026mdash; 12.5 mg\/g\u003c\/th\u003e\u003ctd\u003eMid to deep dermis. Skin hydration and elasticity. The only one in the range formulated with sorbitol instead of mannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe concentration of XXL is lower than that of XL: the range is not a linear ascending scale. XL and XXL\nshare a volumising indication and injection plane, and differ in the rheological behaviour\nof the gel \u0026mdash; the manufacturer positions XXL as a high-viscosity volumiser.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable hyaluronic acid gel intended to fill cutaneous depressions of the face by injection into the dermis. STYLAGE\u0026reg; S Lidocaine is equally indicated for the definition (\u003ci\u003eourlement\u003c\/i\u003e) of the lips by injection into the labial mucosa. The lidocaine hydrochloride is intended to reduce the pain associated with injection.\u003c\/p\u003e\u003cp\u003eBecause of its low consistency, it is the variant of the range intended for the finest and most superficial corrections within the authorised dermal range.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eOutside the indication:\u003c\/b\u003e the instructions for use do not cover treatment of the tear trough, the periorbital region or the restoration of facial volumes, which correspond to other variants or fall outside the intended use of the range.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial to mid dermis of the face; labial mucosa for lip definition.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended techniques:\u003c\/b\u003e retrograde linear injection, multi-puncture technique or a combination of both.\u003c\/li\u003e\n\u003cli\u003eOnly the needles supplied with the product should be used: the combination of both devices has been validated by the manufacturer. Screw the needle firmly onto the Luer-Lock cone.\u003c\/li\u003e\n\u003cli\u003eThe use of sterile CE-marked blunt-tip cannulas is possible. In that case the practitioner must select the appropriate gauge and length and scrupulously observe aseptic conditions, in particular the pre-hole.\u003c\/li\u003e\n\u003cli\u003eInject slowly to avoid overcorrection. If the injection is too deep, the efficacy of the correction is reduced; if it is too superficial, skin discolouration, small indurations or an irregular correction may appear.\u003c\/li\u003e\n\u003cli\u003eThe amount to be injected depends on the defect to be corrected and only the practitioner can define it. Do not overcorrect.\u003c\/li\u003e\n\u003cli\u003eIt is recommended not to inject more than 20 ml of cross-linked hyaluronic acid per person per year (all ranges combined).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSessions:\u003c\/b\u003e depending on the characteristics of the area, of the patient and of the depth of injection, one or two sessions are required for optimal treatment. Regular touch-up sessions allow the correction to be maintained.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAfter injection:\u003c\/b\u003e do not apply cold and massage the treated area thoroughly to optimise the uniformity of the correction.\u003c\/li\u003e\n\u003cli\u003eIn the event of increased pain during the injection, stop the procedure and withdraw the needle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eLaboratoires VIVACY, Archamps Technopole, 74160 Archamps (France)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 16 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine hydrochloride 3 mg\/g\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAntioxidant\u003c\/th\u003e\u003ctd\u003eMannitol\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eIPN-Like (cross-linking) \u0026middot; Bi-SOFT\u0026reg; syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.2 (phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 0.8 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 sterile single-use needles (gauge not specified in the instructions for use)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis; labial mucosa\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eMoist heat (syringe) \/ irradiation or ethylene oxide (needles)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking in accordance with Directive 93\/42\/EEC; notified body 0344. According to the instructions for use, STYLAGE\u0026reg; S Lidocaine obtained CE marking in 2009\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTraceability\u003c\/th\u003e\u003ctd\u003eVIVACY remote authentication system with RFID technology\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e in its original packaging between 2 \u0026deg;C and 25 \u0026deg;C, protected from freezing and from light. Failure to comply with the storage conditions may affect the performance of the product.\u003c\/li\u003e\n\u003cli\u003eIf it has been kept in a refrigerator, allow the product to reach room temperature before injection.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging and on the syringe. Do not use if the packaging is damaged.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise, even if the implant has not been injected. Inject immediately after opening.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 0.8 ml, 4 sterile single-use needles, instructions for use and labels with the batch number \u0026mdash; one for the patient and one for the medical record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eMust not be used:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ein combination with a peel, a laser treatment or dermabrasion (the practitioner decides the waiting period required after these treatments)\u003c\/li\u003e\n\u003cli\u003ein patients with a tendency to develop hypertrophic scars\u003c\/li\u003e\n\u003cli\u003ein patients with known hypersensitivity to any of the components\u003c\/li\u003e\n\u003cli\u003ein pregnant or breastfeeding women, or in children\u003c\/li\u003e\n\u003cli\u003ein areas or in the vicinity of areas with inflammatory or infectious skin problems (acne, herpes, etc.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eIn addition, because of its lidocaine content,\u003c\/b\u003e it must not be used in patients with known hypersensitivity to amide-type local anaesthetics or in patients with porphyria. Combination with certain medicinal products that reduce or inhibit hepatic metabolism is not advised. Lidocaine hydrochloride may induce a positive reaction in anti-doping tests.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePrecautions for use:\u003c\/b\u003e it is strongly recommended to obtain the patient's informed consent. In patients with a history of herpes, the punctures may trigger a new outbreak. In patients with declared autoimmune disease or a history thereof, the practitioner must decide on a case-by-case basis, propose a prior double test and not inject if the disease is progressive. Patients with a history of streptococcal disease (recurrent tonsillitis, rheumatic fever) must undergo a prior double test; in the case of rheumatic fever with cardiac involvement, injection is not recommended. In the case of a haemostatic disorder or anticoagulant therapy, the risk of haematoma is increased. The intake of aspirin, NSAIDs, antiplatelet agents, anticoagulants or vitamin C should be avoided in the week before injection.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eVascular risk:\u003c\/b\u003e do not inject into blood vessels. Accidental intravascular injection may cause vascular occlusion with rare but serious complications — visual disturbances, blindness, necrosis of the skin and\/or of the underlying tissues — depending on the area injected. Do not inject into nerves: accidental nerve injury may cause transient paraesthesia.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of Laboratoires VIVACY (OPDC340 v4) and on the manufacturer's technical documentation. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Vivacy","offers":[{"title":"Default Title","offer_id":51007635587412,"sku":null,"price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/stylage_s.jpg?v=1747753268"},{"product_id":"teosyal-rha-3","title":"Teosyal RHA 3 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eTeosyal RHA\u0026reg; 3 occupies the intermediate position of the Resilient Hyaluronic Acid range: 23 mg\/ml of hyaluronic acid with cross-linking below 5 %, more cross-linked than RHA 2 and less than RHA 4. It is the versatile reference of the range \u0026mdash; deep wrinkles, midface volume and remodelling of the lower third \u0026mdash; and the first to be supplied with a 27G \u0026frac12;\" needle.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 23 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linking\u003c\/b\u003e \u0026lt; 5 % (NMR)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 0.3 % (3 mg\/ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes \u0026times; 1 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 \u0026times; 27G \u0026frac12;\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e 12\u0026ndash;18 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 23 mg\/ml.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eDegree of cross-linking:\u003c\/b\u003e \u0026lt; 5 %, measured by nuclear magnetic resonance. \u003cb\u003eIntermediate\u003c\/b\u003e cross-linking within the RHA range, above RHA 2 and below RHA 4 (FDA, \u003ci\u003eSummary of Safety and Effectiveness Data\u003c\/i\u003e P170002).\u003c\/li\u003e\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 0.3 % by mass (3 mg\/ml).\u003c\/li\u003e\u003cli\u003e\u003cb\u003eResidual BDDE:\u003c\/b\u003e \u0026lt; 1 ppm.\u003c\/li\u003e\u003cli\u003e\u003cb\u003ePhosphate buffer\u003c\/b\u003e pH 7.3 q.s. for 1 ml.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eRHA technology (Resilient Hyaluronic Acid):\u003c\/b\u003e Teoxane's patented manufacturing process (\u003ci\u003ePreserved Network Technology\u003c\/i\u003e) that applies minimal chemical modification and preserves the long hyaluronic acid chains. The result is a gel of low cross-linking (\u0026lt; 5 %) able to stretch and recover its shape with facial movement, instead of resisting it like a conventional rigid gel.\u003c\/li\u003e\u003cli\u003e\u003cb\u003ePractical consequence:\u003c\/b\u003e a gel with the capacity to sustain volume in the midface and to fill deep folds, while maintaining the adaptation to movement that characterises the range. The step up in gauge to 27G \u0026frac12;\" reflects that greater firmness.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Teosyal RHA range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eRHA 1\u003c\/th\u003e\u003ctd\u003eHA 15 mg\/ml \u0026middot; 1 ml \u0026middot; 30G \u0026frac12;\" \u0026mdash; superficial fine lines and skin quality \u0026middot; \u0026ge; 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRHA 2\u003c\/th\u003e\u003ctd\u003eHA 23 mg\/ml \u0026middot; 1 ml \u0026middot; 30G \u0026frac12;\" \u0026mdash; moderate wrinkles, midface and lips \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRHA 3 \u003cb\u003e(this product)\u003c\/b\u003e\u003c\/th\u003e\u003ctd\u003eHA 23 mg\/ml \u0026middot; 1 ml \u0026middot; 27G \u0026frac12;\" \u0026mdash; deep wrinkles, midface volume and remodelling of the lower third \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRHA 4\u003c\/th\u003e\u003ctd\u003eHA 23 mg\/ml \u0026middot; 1.2 ml \u0026middot; 27G \u0026frac12;\" \u0026mdash; deep wrinkles in thick skin and remodelling of the facial contour \u0026middot; 15\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRHA Kiss\u003c\/th\u003e\u003ctd\u003eHA 23 mg\/ml \u0026middot; 0.7 ml \u0026middot; 30G \u0026frac12;\" \u0026mdash; perioral region and lips \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\u003cp\u003eAll references of the RHA range share a \u003cb\u003edegree of cross-linking below 5 %\u003c\/b\u003e, determined by nuclear magnetic resonance, and 0.3 % lidocaine. Within that margin the cross-linking increases in steps: RHA 2 is the least cross-linked, RHA 3 occupies an intermediate position and RHA 4 is the most cross-linked (FDA, \u003ci\u003eSummary of Safety and Effectiveness Data\u003c\/i\u003e P170002). That progression determines the firmness of the gel, the needle gauge supplied and the injection depth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eTherapeutic indication:\u003c\/b\u003e reconstructive surgery, filling of scar depressions and reconstruction of volumes lost through lipoatrophy in patients under treatment for HIV.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAesthetic indication:\u003c\/b\u003e correction of deep facial wrinkles and marked skin folds, and provision of volume in:\u003c\/p\u003e\u003cul\u003e\u003cli\u003eMidface: nasolabial folds, cheekbones, nasojugal groove\u003c\/li\u003e\u003cli\u003eLower third: chin and jawline\u003c\/li\u003e\u003cli\u003ePerioral region: lips (including the philtrum), marionette lines, oral commissures\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e at variable depth \u0026mdash; dermis, subcutaneous plane, supraperiosteal, or subdermis and submucosa of the red lip.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 27G \u0026frac12;\", two per syringe (4 per pack).\u003c\/li\u003e\u003cli\u003e\u003cb\u003eCannula:\u003c\/b\u003e a valid alternative is a 25G blunt cannula; compatibility verified by the manufacturer with TSK 25G\/50 mm.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eMaximum volume:\u003c\/b\u003e 6 ml per session. In the lips a maximum of 2 ml is recommended.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eEstimated duration:\u003c\/b\u003e between 12 and 18 months.\u003c\/li\u003e\u003cli\u003eDo not inject into the epidermis. Do not combine in the same session with peeling, laser or ultrasound.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eTeoxane SA (Laboratoires Teoxane), Geneva, Switzerland\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 23 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDegree of cross-linking\u003c\/th\u003e\u003ctd\u003e\u0026lt; 5 % (NMR) \u0026mdash; intermediate within the RHA range\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine HCl 0.3 % by mass\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE, residual \u0026lt; 1 ppm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTechnology\u003c\/th\u003e\u003ctd\u003eRHA \u0026mdash; Resilient Hyaluronic Acid\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.3 (phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 \u0026times; 27G \u0026frac12;\" (2 per syringe)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCompatible cannula\u003c\/th\u003e\u003ctd\u003e25G (TSK 25G\/50 mm verified)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTreatment plane\u003c\/th\u003e\u003ctd\u003eDermis, subcutaneous, supraperiosteal, subdermis or labial submucosa\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEstimated duration\u003c\/th\u003e\u003ctd\u003e12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 \u0026deg;C and 25 \u0026deg;C, protected from direct sunlight.\u003c\/li\u003e\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise the syringe or the needles.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 1 ml, 4 sterile 27G \u0026frac12;\" needles, and two traceability labels per syringe \u0026mdash; one to be given to the patient and one for the medical record.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e skin disorders, inflammation or infection in or near the treatment area; allergy to hyaluronic acid and a history of severe allergy or anaphylactic shock; allergy to lidocaine or to amide-type local anaesthetics; recent peel, laser or ultrasound treatment; autoimmune diseases; heart disease or treatment with beta-blockers; hepatocellular insufficiency or treatment for liver disease; epilepsy; porphyria; pregnancy, breastfeeding and patients under 18 years of age.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eVascular warning:\u003c\/b\u003e intravascular injection may cause vascular occlusion, ischaemia and necrosis of the treated area. In the most serious cases it may lead to visual disturbances or blindness and to cerebral ischaemia or haemorrhage. Never inject intravascularly.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eBefore injection:\u003c\/b\u003e do not treat if a dental procedure has been performed in the previous 15 days; avoid aspirin, anti-inflammatory drugs, anticoagulants and vitamin E during the preceding week; avoid alcohol and intense sun exposure on the previous day and on the day itself; remove make-up completely.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAfter injection:\u003c\/b\u003e during the first 12 hours, do not apply make-up or undertake intense exertion; during the following week, avoid alcohol, prolonged sun or UV exposure, temperatures below 0 \u0026deg;C, sauna and hammam; for 15 days, do not undergo dental procedures or other aesthetic treatments.\u003c\/p\u003e\u003cp\u003eAlways consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Teoxane SA (instructions for use TEOSYAL RHA\u0026reg; 3, ref. 230581-00, and patient product information). This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Teoxane","offers":[{"title":"Default Title","offer_id":51007637258580,"sku":null,"price":138.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/teosyal_rha3.jpg?v=1747778133"},{"product_id":"teosyal-puresense-redensity-2","title":"Teosyal PureSense Redensity 2 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eTeosyal\u0026reg; PureSense Redensity 2 is Teoxane's periorbital reference: 15 mg\/ml of hyaluronic acid with a degree of cross-linking below 10 %, combined with the same dermo-restructuring complex of 8 amino acids, 3 antioxidants, vitamin B6, zinc and copper as Redensity 1. It is formulated specifically for the tear trough and the eye contour, where the skin is thin and water retention must be contained.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 15 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linking\u003c\/b\u003e \u0026lt; 10 % (NMR)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 0.3 % (3 mg\/ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes \u0026times; 1 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 4 \u0026times; 30G \u0026frac12;\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e \u0026ge; 12 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 15 mg\/ml.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eDegree of cross-linking:\u003c\/b\u003e \u0026lt; 10 %, measured by nuclear magnetic resonance.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 0.3 % by mass (3 mg\/ml).\u003c\/li\u003e\u003cli\u003e\u003cb\u003eResidual BDDE:\u003c\/b\u003e \u0026lt; 1 ppm.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eDermo-restructuring complex (supplemented phosphate buffer, pH 7.3):\u003c\/b\u003e the buffer is not inert, it incorporates the following active components:\u003cul\u003e\u003cli\u003e\u003cb\u003e3 antioxidants:\u003c\/b\u003e \u0026alpha;-lipoic acid, glutathione and N-acetyl-L-cysteine.\u003c\/li\u003e\u003cli\u003e\u003cb\u003e8 amino acids:\u003c\/b\u003e L-arginine, L-isoleucine, L-leucine, L-lysine monohydrate, glycine, L-valine, L-threonine and L-proline \u0026mdash; precursors for collagen and elastin synthesis.\u003c\/li\u003e\u003cli\u003e\u003cb\u003e1 vitamin:\u003c\/b\u003e pyridoxine (vitamin B6) in the form of the hydrochloride.\u003c\/li\u003e\u003cli\u003e\u003cb\u003e2 minerals:\u003c\/b\u003e zinc acetate dihydrate and copper sulphate pentahydrate, enzyme cofactors.\u003c\/li\u003e\u003cli\u003eSodium chloride.\u003c\/li\u003e\u003c\/ul\u003eThe manufacturer does not publish the individual concentrations of these components.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eDifference from Redensity 1:\u003c\/b\u003e the same HA concentration and the same associated complex, but Redensity 2 is indeed cross-linked. This allows it to create a volume that corrects the trough, whereas Redensity 1 only redensifies. The estimated duration goes from at least 3 months to at least 12.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Teosyal PureSense range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eRedensity 1\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eNon-cross-linked\u003c\/b\u003e HA 15 mg\/ml + dermo-restructuring complex \u0026middot; 1 ml \u0026middot; 30G \u0026frac12;\" \u0026mdash; skin quality and hydration \u0026middot; \u0026ge; 3 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRedensity 2 \u003cb\u003e(this product)\u003c\/b\u003e\u003c\/th\u003e\u003ctd\u003eHA 15 mg\/ml (cross-linking \u0026lt; 10 %) + dermo-restructuring complex \u0026middot; 1 ml \u0026middot; 30G \u0026frac12;\" \u0026mdash; periorbital region and tear trough \u0026middot; \u0026ge; 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eGlobal Action\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml \u0026middot; 1 ml \u0026mdash; wrinkles and skin depressions, lips \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDeep Lines\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml \u0026middot; 1 ml \u0026mdash; marked wrinkles and depressions \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eKiss\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml (cross-linking \u0026lt; 10 %) \u0026middot; 1 ml \u0026middot; 27G \u0026frac12;\" \u0026mdash; lips and perioral region \u0026middot; 12\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUltra Deep\u003c\/th\u003e\u003ctd\u003eHA 25 mg\/ml (cross-linking \u0026lt; 10 %) \u0026middot; 1.2 ml \u0026middot; 25G 1\" \u0026mdash; facial volume and contour \u0026middot; 15\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUltimate\u003c\/th\u003e\u003ctd\u003eHA 22 mg\/ml \u0026middot; 1 ml \u0026mdash; facial contour \u0026middot; 15\u0026ndash;18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\u003cp\u003eThe cross-linked PureSense range declares a \u003cb\u003edegree of cross-linking below 10 %\u003c\/b\u003e (NMR), compared with the \u0026lt; 5 % of the RHA range. It is a firmer gel with a greater capacity for projection at an equal concentration; the RHA range instead prioritises adaptation to movement in areas of high facial animation. Redensity 1 falls outside this logic: it is not cross-linked and provides no volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eCorrection of superficial fine lines and wrinkles and of depressions in:\u003c\/p\u003e\u003cul\u003e\u003cli\u003e\u003cb\u003ePeriorbital region:\u003c\/b\u003e dark circles \u0026mdash; tear trough and palpebromalar groove \u0026mdash;, eyebrows, lateral canthus and crow's feet\u003c\/li\u003e\u003cli\u003e\u003cb\u003eMidface:\u003c\/b\u003e nasojugal groove\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003e\u003cb\u003eContraindication specific to this reference:\u003c\/b\u003e it must not be used in the presence of eyelid bags or laxity of the lower eyelid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e dermis, subcutaneous or supraperiosteal plane.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 30G \u0026frac12;\", two per syringe (4 per pack).\u003c\/li\u003e\u003cli\u003e\u003cb\u003eMaximum volume:\u003c\/b\u003e 6 ml per session; in the tear trough, \u003cb\u003ea maximum of 0.5 ml per side\u003c\/b\u003e.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eEstimated duration:\u003c\/b\u003e at least 12 months.\u003c\/li\u003e\u003cli\u003eDo not inject into the epidermis. Exercise the utmost caution in the periorbital area because of its vascular risk. Do not combine in the same session with peeling, laser or ultrasound.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eTeoxane SA (Laboratoires Teoxane), Geneva, Switzerland\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 15 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDegree of cross-linking\u003c\/th\u003e\u003ctd\u003e\u0026lt; 10 % (NMR)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine HCl 0.3 % by mass\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE, residual \u0026lt; 1 ppm\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAssociated complex\u003c\/th\u003e\u003ctd\u003e8 amino acids, 3 antioxidants, vitamin B6, zinc and copper\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003epH\u003c\/th\u003e\u003ctd\u003e7.3 (supplemented phosphate buffer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e4 \u0026times; 30G \u0026frac12;\" (2 per syringe)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTreatment plane\u003c\/th\u003e\u003ctd\u003eDermis, subcutaneous or supraperiosteal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eEstimated duration\u003c\/th\u003e\u003ctd\u003eAt least 12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 \u0026deg;C and 25 \u0026deg;C, protected from direct sunlight.\u003c\/li\u003e\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise the syringe or the needles.\u003c\/li\u003e\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 1 ml, 4 sterile 30G \u0026frac12;\" needles, and two traceability labels per syringe \u0026mdash; one to be given to the patient and one for the medical record.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e skin disorders, inflammation or infection in or near the treatment area; allergy to hyaluronic acid and a history of severe allergy or anaphylactic shock; allergy to lidocaine or to amide-type local anaesthetics; recent peel, laser or ultrasound treatment; autoimmune diseases; heart disease or treatment with beta-blockers; hepatocellular insufficiency or treatment for liver disease; epilepsy; porphyria; pregnancy, breastfeeding and patients under 18 years of age.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAdditional contraindication for Redensity 2:\u003c\/b\u003e eyelid bags or laxity of the lower eyelid.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eVascular warning:\u003c\/b\u003e intravascular injection may cause vascular occlusion, ischaemia and necrosis of the treated area. In the most serious cases it may lead to visual disturbances or blindness and to cerebral ischaemia or haemorrhage. Never inject intravascularly.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eBefore injection:\u003c\/b\u003e do not treat if a dental procedure has been performed in the previous 15 days; avoid aspirin, anti-inflammatory drugs, anticoagulants and vitamin E during the preceding week; avoid alcohol and intense sun exposure on the previous day and on the day itself; remove make-up completely.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAfter injection:\u003c\/b\u003e during the first 12 hours, do not apply make-up or undertake intense exertion; during the following week, avoid alcohol, prolonged sun or UV exposure, temperatures below 0 \u0026deg;C, sauna and hammam; for 15 days, do not undergo dental procedures or other aesthetic treatments.\u003c\/p\u003e\u003cp\u003eAlways consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Teoxane SA (instructions for use TEOSYAL\u0026reg; PureSense REDENSITY 2, ref. 230588-00, and patient product information). This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Teoxane","offers":[{"title":"Default Title","offer_id":51007638110548,"sku":null,"price":158.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/teosyal_redensity_2_b9bb1a85-f06c-4b8d-86f7-9efc3428f790.jpg?v=1747754067"},{"product_id":"hyacorp-face","title":"HYAcorp Face 2x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eHYAcorp Face is the classic facial filler from BioScience GmbH: a resorbable cutaneous implant of non-animal hyaluronic acid at 22 mg\/ml, formulated as a biphasic gel and supplied in 2 ml syringes with a Luer Lock connector. It is intended for the restoration of facial volume and contour by implantation in the mid dermis, with a specific indication in moderate to deep folds.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHA\u003c\/b\u003e 22 mg\/ml (20 cross-linked + 2 free)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes × 2.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e mid dermis\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e sterile, included (EO)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout lidocaine\u003c\/b\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003e1 ml of HYAcorp Face contains:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid:\u003c\/b\u003e 2.0 mg\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 20.0 mg\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSodium chloride:\u003c\/b\u003e 6.9 mg\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWater for injections\u003c\/b\u003e q.s. to 1.0 ml\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eBiphasic gel:\u003c\/b\u003e cross-linked hyaluronic acid particles suspended in non-cross-linked hyaluronic acid, which acts as the vehicle. The hyaluronic acid is of non-animal origin and is obtained by fermentation.\u003c\/p\u003e\n\u003cp\u003eSterile, pyrogen-free, viscoelastic, water-insoluble and biologically compatible gel implant (non-immunising, non-inflammatory, non-toxic). It degrades completely over time.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWithout anaesthetic:\u003c\/b\u003e the formulation does not include lidocaine. The manufacturer envisages the use of a local anaesthetic to reduce discomfort during implantation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the HYAcorp references\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eHYAcorp Fine — 1 ml\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 14 mg\/ml. Skin quality: hydration and elasticity. Mid dermis.\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHYAcorp Lips — 1 ml\u003c\/th\u003e\u003ctd\u003eHA 18 mg\/ml (16 cross-linked + 2 free). Lip volume and contour.\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHYAcorp Face — 2 ml\u003c\/th\u003e\u003ctd\u003eHA 22 mg\/ml (20 + 2). Moderate and deep folds, nasolabial folds, cheeks, glabella. Mid dermis.\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHYAcorp MLF1 — 10 ml\u003c\/th\u003e\u003ctd\u003eHA 22 mg\/ml, particle size 200–350 µm. Calves, concave deformities, hands. Subcutaneous \/ supraperiosteal.\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHYAcorp MLF2 — 10 ml\u003c\/th\u003e\u003ctd\u003eHA 22 mg\/ml, particle size 300–500 µm. Buttocks and larger volume augmentations. Subcutaneous \/ supraperiosteal.\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eFace shares its concentration with MLF1 and MLF2 but differs in the implantation plane (mid dermis versus subcutaneous\/supraperiosteal) and in syringe volume. The MLF products are contraindicated in the face.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eRestoration of facial volume and contour: replacement of hyaluronic acid lost from the skin and volume replacement by filling folds.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eModerate to deep folds\u003c\/li\u003e\n\u003cli\u003eNasolabial folds\u003c\/li\u003e\n\u003cli\u003eCheek area\u003c\/li\u003e\n\u003cli\u003eGlabellar lines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eDo not inject HYAcorp Face into the periorbital region\u003c\/b\u003e (eyelid, crow's feet, tear troughs).\u003c\/p\u003e\n\u003cp\u003eThe duration of the filling effect varies and depends on the depth and area of injection. The achievable result depends on the skin type and on the change requested.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eImplantation plane:\u003c\/b\u003e mid dermal tissue. Technique and depth are chosen according to the region treated.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePreparation:\u003c\/b\u003e mark the areas to be treated and prepare them carefully under aseptic conditions. A local anaesthetic may be used and, at the physician's discretion, antibiotic prophylaxis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAssembly:\u003c\/b\u003e remove the syringe from the blister, take off the cap and attach one of the sterile needles supplied to the Luer Lock connector.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCorrection:\u003c\/b\u003e correct to a maximum of 100 % of the desired volumising effect. Do not overcorrect.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNever\u003c\/b\u003e inject into blood vessels: risk of vascular occlusion and embolism.\u003c\/li\u003e\n\u003cli\u003eIf a needle becomes blocked, replace it with a new one; do not increase pressure on the plunger.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSyringe graduation:\u003c\/b\u003e this is an indicative reference to the nominal volume of 2 ml, not a measuring function. Sufficient volume is assessed visually and by palpation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAftercare:\u003c\/b\u003e do not expose the area to intense heat (sun, solarium, laser, IPL) or extreme cold; avoid sporting exertion for a few days; do not massage or press the area over the following days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe physician's experience and specific training in injection techniques are decisive for the treatment result.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eBioScience GmbH — Walsmühler Straße 18, 19073 Dümmer, Germany\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive ingredient\u003c\/th\u003e\u003ctd\u003eHyaluronic acid 22 mg\/ml (20 mg cross-linked + 2 mg free)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin\u003c\/th\u003e\u003ctd\u003eNon-animal, obtained by fermentation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eExcipients\u003c\/th\u003e\u003ctd\u003eSodium chloride 6.9 mg\/ml; water for injections\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 2.0 ml with integrated Luer Lock adapter, in a blister\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003eSterile needles included (ethylene oxide sterilised); the package insert states 2 needles per 2 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSterilisation\u003c\/th\u003e\u003ctd\u003eSyringe contents steam sterilised\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute\u003c\/th\u003e\u003ctd\u003eImplantation in the mid dermis\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device, single use\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e at room temperature, between 2 °C and 25 °C. Do not freeze or expose to extreme heat.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack includes:\u003c\/b\u003e 2 ml syringes in a blister, sterile needles, instructions for use and labels with batch number and expiry date. One label is given to the patient to ensure traceability.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not re-sterilise, do not mix with other injectable products and do not transfer to another container.\u003c\/li\u003e\n\u003cli\u003eDo not use if the packaging or blister is damaged, or after the expiry date.\u003c\/li\u003e\n\u003cli\u003eUsed syringes and needles are considered contaminated and must be disposed of in accordance with the rules of medical practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications according to the manufacturer:\u003c\/b\u003e tendency to hypertrophic scars and keloids; intolerance to Gram-positive bacteria; active inflammatory or infectious processes; acute or chronic skin diseases; anticoagulant therapy; known allergy to hyaluronic acid; autoimmune diseases.\u003c\/p\u003e\n\u003cp\u003eThere are no clinical data on use in pregnant women, breastfeeding women or patients under 18 years of age. Patients with multiple allergies must be excluded from treatment.\u003c\/p\u003e\n\u003cp\u003eThe use of HYAcorp Face for \u003cb\u003ebreast\u003c\/b\u003e and \u003cb\u003egenital\u003c\/b\u003e augmentation is contraindicated. Nor should it be injected into the \u003cb\u003eperiorbital region\u003c\/b\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e do not inject into blood vessels. Do not inject into areas where a permanent implant has been placed or into areas already treated with another filler material. Particular caution is required in the vicinity of vulnerable structures such as nerves and vessels. Patients taking substances that affect coagulation (acetylsalicylic acid, NSAIDs) may show increased bleeding or bruising at the injection site.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eReported adverse events:\u003c\/b\u003e pruritus, redness, tenderness and swelling at the puncture site, subcutaneous bleeding or haematomas, indurations and hypersensitivity reactions, usually resolving spontaneously within one or two weeks. Very rare late reactions: bacterial infections, biofilm formation, chronic inflammatory nodules, reactivation of herpes infections, migration of the material, skin necrosis, foreign body reactions and granulomas. The technique may give rise to overcorrection or bluish discolouration (Tyndall effect).\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use enclosed in the packaging before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official instructions for use of BioScience GmbH (HYAcorp Face package insert) and on the product documentation published by the manufacturer at bio-science.org. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"BioScience","offers":[{"title":"Default Title","offer_id":51007641715028,"sku":null,"price":142.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/hyacorp_face.jpg?v=1752163427"},{"product_id":"aqualyx-10x8ml","title":"Aqualyx 10x8ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eAqualyx® is the injectable solution from the deoxycholic acid family developed by Prof. Pasquale Motolese for Marllor Biomedical, intended for the remodelling of localised fat accumulations by means of the intralipotherapy technique. It is presented in 8 ml vials and has been the reference product for this technique for more than fifteen years.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eBase\u003c\/b\u003e deoxycholic acid family\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 10 vials × 8 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique\u003c\/b\u003e intralipotherapy\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e subcutaneous adipose tissue\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFormulation\u003c\/b\u003e Prof. P. Motolese\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eActive substance:\u003c\/b\u003e compound of the deoxycholic acid family, according to the manufacturer's description. Deoxycholate is a bile salt with a detergent action on the adipocyte membrane.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFormulation:\u003c\/b\u003e developed by Prof. Pasquale Motolese, who is also the author of the intralipotherapy technique with which the product is applied.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eThe manufacturer does not publish openly the concentration of the active substance, the buffer system or the complete list of excipients.\u003c\/b\u003e Consult the data sheet accompanying the product and the vial labelling before use.\u003c\/p\u003e\n\u003cp\u003eMarllor also markets a separate reference for the lower facial third — Aqualyx® Face — in kit format and with its own complementary serum (Seralyx). The two references are not interchangeable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eIndication:\u003c\/b\u003e remodelling of the body contour in localised and resistant fat accumulations, in normal-weight patients. It is not a treatment for obesity or a substitute for liposuction.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eUsual body areas:\u003c\/b\u003e abdomen, flanks, inner thighs and knees, arms and dorsal region (upper back).\u003c\/p\u003e\n\u003cp\u003eFor the treatment of the lower facial third and the submental area, the manufacturer offers a specific reference (Aqualyx® Face).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e intralipotherapy. The product is deposited in the \u003cb\u003esubcutaneous adipose tissue\u003c\/b\u003e, not in the dermis or in the muscular plane.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eApproach:\u003c\/b\u003e the technique described by the author of the formulation uses long small-gauge needles, with fan-shaped distribution of the product from a small number of entry points, so that the adipose panniculus is treated homogeneously.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePreparation:\u003c\/b\u003e rigorous disinfection of the area to be treated before puncture. Prior marking of the area with the patient standing.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSessions:\u003c\/b\u003e the treatment is planned as a cycle of several spaced sessions. \u003cb\u003eApply the number of sessions, the interval and the maximum volume per session and per area given in the documentation accompanying the product\u003c\/b\u003e — the manufacturer does not publish those values openly.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAftercare:\u003c\/b\u003e compression and drainage according to the clinic's protocol. Oedema, erythema and local tenderness in the treated area are to be expected over the following days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eApplication requires specific training in the intralipotherapy technique and precise knowledge of the anatomy of the adipose plane of the area treated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMarllor Biomedical, Via Torconca 1, 47842 S. Giovanni in Marignano (RN), Italy\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eFormulation\u003c\/th\u003e\u003ctd\u003eProf. Pasquale Motolese\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCompound of the deoxycholic acid family (concentration not published by the manufacturer)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e10 vials of 8.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute\u003c\/th\u003e\u003ctd\u003eInjectable into subcutaneous adipose tissue (intralipotherapy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003eNot included\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eThe manufacturer currently presents this reference under the designation \"Aqualyx Cosmetic\" and does not publish openly its current regulatory classification. Verify the marking and the documentation of the pack received\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eExclusively qualified healthcare professionals trained in the technique\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 10 vials of 8.0 ml. Needles are not included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e keep the vials in their original packaging, protected from direct sunlight and from heat sources, in accordance with the indications on the packaging.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown.\u003c\/li\u003e\n\u003cli\u003eSingle-use vials. Do not reuse the remainder or resterilise.\u003c\/li\u003e\n\u003cli\u003eThe manufacturer incorporates authentication QR codes on its packaging; verify the traceability of the unit received.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eRelevant safety warning:\u003c\/b\u003e injectable solutions based on deoxycholate have a non-selective cytolytic action. The literature records published cases of \u003cb\u003eskin necrosis\u003c\/b\u003e after injection that is too superficial and of \u003cb\u003enodules and chronic infection\u003c\/b\u003e after adipocytolytic treatments. The correct depth of the deposit in the adipose plane and strict asepsis are decisive.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eGeneral contraindications and precautions for this class of product:\u003c\/b\u003e known hypersensitivity to deoxycholate or to any excipient; pregnancy and breastfeeding; minors; active infection or inflammation, wound or dermatosis in the area to be treated; coagulation disorders or anticoagulant therapy; obesity as an indication (the product is intended for localised accumulations in normal-weight patients); hernias, scars or implants in the puncture area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDo not inject\u003c\/b\u003e into the dermis, into the muscular plane or intravascularly. Do not apply over areas with impaired cutaneous vascularisation.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use and the complete list of contraindications accompanying the product before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eProduct intended exclusively for qualified healthcare professionals with specific training in the technique. Technical information based on the documentation published by Marllor Biomedical and on peer-reviewed scientific literature on intralipotherapy and adipocytolytic solutions. The manufacturer does not publish openly the quantitative composition, the dosing protocol or the current regulatory classification of this reference: this data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Marllor Biomedical","offers":[{"title":"Default Title","offer_id":51007643386196,"sku":null,"price":156.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/aqualyx-phosphatidylcholin-lipolyse_600x_fa91ca5a-382b-412c-8377-13942050095d.webp?v=1735927848"},{"product_id":"dr-cyj-hair-filler","title":"Dr. CYJ Hair Filler 2x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eDR. CYJ Hair Filler is the injectable hair treatment from Caregen Co., Ltd. (South Korea), developed by Dr Yong Ji Chung on the basis of the company's biomimetic peptide technology. It combines seven synthetic peptides directed at different pathways of follicle biology with a hyaluronic acid vehicle that prolongs their residence in the dermis of the scalp. It is not a volumetric filler: it is applied as intradermal microinjections following a protocol of fortnightly sessions.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eActive\u003c\/b\u003e complex of 7 peptides\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVehicle\u003c\/b\u003e hyaluronic acid\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 syringes × 1.0 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle\u003c\/b\u003e 30G–32G\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 4 sessions \/ every 2 weeks\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePatented peptide complex\u003c\/b\u003e of seven synthetic peptides: decapeptide-18, decapeptide-10, decapeptide-28, octapeptide-2, octapeptide-11, oligopeptide-54 and oligopeptide-71. Each acts on a different pathway of follicular biology — stimulation of the follicle stem cells, prolongation of the anagen phase, anti-inflammatory effect and reduction of shedding.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid\u003c\/b\u003e as a vehicle: it keeps the peptide complex in the dermal plane and prolongs its contact time with the follicle compared with a simple aqueous solution.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBiomimetic peptide technology:\u003c\/b\u003e the peptides reproduce sequences of endogenous growth factors and signalling molecules, with the aim of acting on the same receptors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable product indicated for the treatment of the scalp in adult patients.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAndrogenetic alopecia\u003c\/li\u003e\n\u003cli\u003eTelogen effluvium\u003c\/li\u003e\n\u003cli\u003eWeakening and thinning of the hair shaft\u003c\/li\u003e\n\u003cli\u003eLoss of hair density\u003c\/li\u003e\n\u003cli\u003eScalp with chemical or thermal damage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePreparation:\u003c\/b\u003e mark the treatment areas and disinfect the scalp before application.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 30G–32G.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAngle and plane:\u003c\/b\u003e insert at an angle of approximately 30° to the surface of the scalp, in the superficial to mid dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDistribution of the points:\u003c\/b\u003e points spaced 0.2 to 0.3 cm apart within a 1 cm line.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVolume per point:\u003c\/b\u003e 0.02–0.05 ml.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eApplication:\u003c\/b\u003e apply uniform pressure to the plunger during injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eStandard protocol:\u003c\/b\u003e \u003cb\u003e4 sessions, one every 2 weeks, over 8 weeks.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMaintenance:\u003c\/b\u003e monthly sessions for 3 to 6 months after completing the initial regimen.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOnset of the result:\u003c\/b\u003e the first changes are observed between 2 and 3 weeks after the fourth session; the full effect is established over 2 to 3 months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe pack of 2 syringes of 1.0 ml covers two sessions of the standard regimen.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCaregen Co., Ltd. — South Korea\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eComplex of 7 synthetic peptides (decapeptide-18, decapeptide-10, decapeptide-28, octapeptide-2, octapeptide-11, oligopeptide-54, oligopeptide-71)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eVehicle\u003c\/th\u003e\u003ctd\u003eHyaluronic acid\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 pre-filled syringes of 1.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedle\u003c\/th\u003e\u003ctd\u003e30G–32G\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eInjection plane\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis of the scalp\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProtocol\u003c\/th\u003e\u003ctd\u003e4 sessions, one every 2 weeks\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eExclusively qualified healthcare professionals with specific training\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e keep in the original packaging, protected from light, under the temperature conditions indicated on it. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or resterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 pre-filled syringes of 1.0 ml, instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e pregnancy and breastfeeding; under 18 years of age; known hypersensitivity to any of the components of the formulation; active infection or inflammation of the scalp; active dermatosis in the treatment area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCaution:\u003c\/b\u003e assess individually in patients on anticoagulant or antiplatelet therapy.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eExpected reactions:\u003c\/b\u003e redness, oedema, pruritus and mild discomfort in the treated area, transient in nature and usually resolved within 72 hours.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer restricts use to professionals with specific training or working in accredited centres. Always consult the instructions for use included in the pack before application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eProduct intended exclusively for qualified healthcare professionals. Technical information based on the documentation of the manufacturer Caregen Co., Ltd. and of its official distribution. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Caregen","offers":[{"title":"Default Title","offer_id":51280909664596,"sku":"","price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/dr_cyj.jpg?v=1747750744"},{"product_id":"profhilo-structura-1x-2-0ml","title":"Profhilo Structura 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eProfhilo® Structura from IBSA Derma is the variant of the Profhilo range aimed at volume loss due to atrophy of facial adipose tissue. It concentrates 90 mg of \u003cb\u003enon-cross-linked\u003c\/b\u003e hyaluronic acid in 2 ml — 45 mg of high molecular weight and 45 mg of low molecular weight — stabilised by NAHYCO® thermal technology. Unlike Profhilo H+L, which acts in the dermal plane, Structura is applied with a cannula in the superficial fat compartment.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eNon-cross-linked HA\u003c\/b\u003e 90 mg \/ 2 ml (4.5 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eH-HA + L-HA\u003c\/b\u003e 45 mg + 45 mg\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eApplication\u003c\/b\u003e with cannula, superficial fat plane\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 2 sessions \/ 30 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eHigh molecular weight hyaluronic acid (H-HA):\u003c\/b\u003e 45 mg per 2 ml syringe, 1,100–1,400 kDa.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLow molecular weight hyaluronic acid (L-HA):\u003c\/b\u003e 45 mg per 2 ml syringe, 80–100 kDa.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTotal concentration:\u003c\/b\u003e 90 mg \/ 2 ml, equivalent to 45 mg\/ml (4.5 %). This is the highest concentration in the Profhilo range.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNAHYCO® technology:\u003c\/b\u003e patented thermal process that combines the two molecular weight fractions by controlled heating and cooling. As the hydrogen bonds break and re-form, stable Hybrid Cooperative Complexes (\u003ci\u003eHybrid Cooperative Complexes\u003c\/i\u003e, HCC) are generated. \u003cb\u003eWithout BDDE or any other chemical cross-linking agent.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRheological profile:\u003c\/b\u003e G' of approximately 95 Pa. A deliberately low value compared with that of a volumetric filler: the objective is not mechanical projection, but integration into the fat compartment.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDifferentiating mechanism:\u003c\/b\u003e the manufacturer describes an action restoring adipose tissue (\u003ci\u003elipolifting\u003c\/i\u003e), aimed at the age-related atrophy of the facial fat compartments, and not at volume replacement by implant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the Profhilo variants\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo H+L\u003c\/th\u003e\u003ctd\u003e64 mg \/ 2 ml (32 mg H-HA + 32 mg L-HA) — laxity and remodelling of the facial contour, dermal\/subcutaneous plane, BAP technique with a 29G needle\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo Structura\u003c\/th\u003e\u003ctd\u003e90 mg \/ 2 ml (45 mg H-HA + 45 mg L-HA) — atrophy of facial adipose tissue, superficial fat compartment, retrograde application with a cannula\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProfhilo Body\u003c\/th\u003e\u003ctd\u003e96 mg \/ 3 ml per syringe, 2 syringes — body skin laxity (abdomen, inner surface of the arms, knees), body BAP technique at 10 points\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eAll three variants share NAHYCO® technology and the absence of a chemical cross-linker. They differ in concentration, application plane and pattern of points. Structura and H+L are not interchangeable: they treat different anatomical planes and can be used complementarily.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eIndicated for the \u003cb\u003erestoration of facial adipose tissue\u003c\/b\u003e in patients with signs of structural ageing due to atrophy of the fat compartments.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLateral fat compartment of the cheek\u003c\/li\u003e\n\u003cli\u003ePreauricular region\u003c\/li\u003e\n\u003cli\u003eZygomatic arch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProduct for facial use only. The range does not currently provide a body indication for this reference; Profhilo Body is used for the body.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial fat compartment (subcutaneous plane), one layer below the dermal plane in which Profhilo H+L is applied.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e retrograde injection \u003cb\u003ewith a cannula\u003c\/b\u003e, not with a needle. A pilot needle is used to create the entry point.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e\"Deflation\" pattern (predominant volume loss):\u003c\/b\u003e 22G × 50 mm cannula, entry point approximately 2 cm from the tragus, 1 ml per hemiface deposited in the preauricular region.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003e\"Sagging\" pattern (predominant laxity):\u003c\/b\u003e 25G × 38 mm cannula, entry point approximately 3 cm from the tragus, 0.5 ml in the preauricular region and 0.5 ml in the zygomatic arch per hemiface.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 2 ml per session, that is, one complete syringe (1 ml per hemiface).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e two sessions with an interval of 30 days.\u003c\/li\u003e\n\u003cli\u003eCompatible with combined protocols within the IBSA Derma range; the sequence with cross-linked fillers or with Profhilo H+L should be planned according to clinical judgement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eIBSA Derma — IBSA Institut Biochimique SA, Switzerland\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eSodium salt of non-cross-linked hyaluronic acid, 90 mg \/ 2 ml (45 mg\/ml)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eFractions\u003c\/th\u003e\u003ctd\u003e45 mg H-HA (1,100–1,400 kDa) + 45 mg L-HA (80–100 kDa)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eNone — NAHYCO® thermal stabilisation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRheological profile\u003c\/th\u003e\u003ctd\u003eG' ≈ 95 Pa\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eNot contained\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eCannula, superficial fat plane (subcutaneous)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 0 °C and 25 °C, away from heat sources. \u003cb\u003eDo not freeze.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise. Sterile and pyrogen-free contents.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2.0 ml, administration material, instructions for use and traceability labels for the patient record.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eManufacturer's warnings:\u003c\/b\u003e do not inject intravenously, intramuscularly or into tendons. Do not mix with other products in the same syringe. It must not be used concomitantly with laser \u003ci\u003eresurfacing\u003c\/i\u003e treatments or with medium-to-deep peels. After injection it is recommended to avoid exposure to ultraviolet radiation for 3–5 days and to use SPF 50 sun protection.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to hyaluronic acid or to any of the components; active skin infection or inflammation in the treatment area; pregnancy and breastfeeding; patients under 18 years of age. Individual assessment in patients with autoimmune disease, coagulation disorders or anticoagulant therapy.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of IBSA Derma and on specialist publications on the Profhilo range. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"IBSA","offers":[{"title":"Default Title","offer_id":51737317769556,"sku":"","price":148.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/profhilo_structura.jpg?v=1745315356"},{"product_id":"sunekos-200-1x-3-0-ml","title":"Sunekos 200 2x1.5ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eSunekos® 200 is the patented biostimulator from Professional Dietetics that combines low density hyaluronic acid with six amino acid precursors of the extracellular matrix. Unlike a conventional hyaluronic acid skinbooster, it supplies the substrates for collagen and elastin synthesis. It is the first-line product of the range and is applied with a fixed schedule of four sessions.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eFormula\u003c\/b\u003e HA + 6 amino acids\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHA density\u003c\/b\u003e low\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 2 vials (1 treatment)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 27G–30G, 12–13 mm\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 4 sessions every 7–10 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid (sodium hyaluronate)\u003c\/b\u003e of low density, non-cross-linked.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePatented complex of six amino acids:\u003c\/b\u003e glycine, L-proline, L-leucine, L-lysine HCl, L-valine and L-alanine, sterile and apyrogenic.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eRationale of the formula:\u003c\/b\u003e glycine, proline and lysine are the predominant residues of the collagen triple helix; the set of six amino acids supplies the precursors for collagen and elastin synthesis, while the hyaluronic acid acts as a vehicle and as the aqueous component of the extracellular matrix. The stated objective of the product is the regeneration of the dermal extracellular matrix, not the provision of volume.\u003c\/p\u003e\n\u003cp\u003eThe product is supplied in two vials that are combined immediately before injection. Consult the pack labelling for the exact content of each vial and for the exact proportions of the formula, which the manufacturer keeps proprietary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eDifferences between the injectable references\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eSunekos® 200\u003c\/th\u003e\u003ctd\u003eLow density hyaluronic acid + 6 amino acids. First-line product, suitable for all dermal types. Areas: face and periocular area\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSunekos® 1200\u003c\/th\u003e\u003ctd\u003eMedium-high density hyaluronic acid (1200 kDa) + the same amino acids. Used as a \"cushion\" or structural scaffold preceding the protocol with Sunekos® 200. Area: face\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSunekos® Performa\u003c\/th\u003e\u003ctd\u003eLow molecular weight hyaluronic acid with a new proportion of the six amino acids. Pre-mixed format. Areas: face, periocular area and neck\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eSunekos® Body\u003c\/th\u003e\u003ctd\u003eBody reference for stretch marks, laxity and roughness. Areas: arms, abdomen, knees and inner thigh\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eSunekos® 200 is the first-line product of the range and, according to the manufacturer, is suitable for all dermal types.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eAreas covered in the manufacturer's techniques manual:\u003c\/b\u003e face, neck, décolleté, hands, dark circles and eyelid bags, forehead and inner thigh. The manufacturer's product page states the face and the periocular area as areas of use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eStandard protocol:\u003c\/b\u003e 4 treatments with Sunekos® 200 at intervals of 7 to 10 days.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eMaintenance:\u003c\/b\u003e repeat at 6 months. Manufacturer's alternative: 2 treatments every 3 or 4 months, repeating the full protocol of 4 treatments every 12 months.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 27G–30G of 12–13 mm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane:\u003c\/b\u003e mid-deep dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e micro-bolus or linear retrograde injection, 0.1 ml per point.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eIFT (Interstitial Fluid Technique):\u003c\/b\u003e proprietary technique developed by the medical team of Professional Dietetics. Linear retrograde injection at 45°, a series of boluses about 1.5 cm apart, in the direction of the interstitial flow, with subsequent massage following that flow. Centrifugal direction for a lifting effect in relatively young, rounded faces; centripetal direction for a volumising effect in narrow or deflated faces, generally in patients over 45 years of age.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eForehead:\u003c\/b\u003e 25G or 27G 50 mm cannula, deep dermis, fanning technique, half a vial per side, sessions every 14 days.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDark circles and bags:\u003c\/b\u003e 3 sessions at 14-day intervals, half a vial per side, 0.1 ml per point.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCombination with Sunekos® 1200:\u003c\/b\u003e in thin skin with laxity and marked wrinkles, 1 treatment with Sunekos® 1200 as a scaffold followed —on the same day or at most 1 or 2 days later— by 3 or 4 treatments of Sunekos® 200 at intervals of 7–10 days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eAnatomical caution in the periocular area:\u003c\/b\u003e the manufacturer warns that the orbital septum must never be reached. There is no vascularisation over the orbital septum and any injection into it may cause damage. In zone A inject parallel to the skin and very superficially; in zone B inject perpendicularly until bone is contacted. Inspect the skin to avoid small-calibre veins and reduce the number of points if necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eProfessional Dietetics S.p.A., Via Ciro Menotti 1\/A, 20129 Milan (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substances\u003c\/th\u003e\u003ctd\u003eLow density sodium hyaluronate + patented complex of 6 amino acids\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAmino acids\u003c\/th\u003e\u003ctd\u003eGlycine, L-proline, L-leucine, L-lysine HCl, L-valine, L-alanine\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eNot contained\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 vials combined before injection (1 treatment)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e27G–30G, 12–13 mm (not included)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eInjection plane\u003c\/th\u003e\u003ctd\u003eMid-deep dermis\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProtocol\u003c\/th\u003e\u003ctd\u003e4 sessions at intervals of 7–10 days; maintenance at 6 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eInjectable class III medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e the two vials of the treatment. Needles and cannulas are not included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e store the vials in their original packaging, protected from direct light and from heat sources, in accordance with the indications on the pack.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCombined product:\u003c\/b\u003e prepare at the time of the session and use immediately.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated.\u003c\/li\u003e\n\u003cli\u003eSterile single-use vials. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e known hypersensitivity to hyaluronic acid or to any of the amino acids of the formula; pregnancy and breastfeeding; minors; active infection or inflammation in the area to be treated; flaring dermatosis over the puncture area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e do not inject intravascularly. In the periocular area, do not reach the orbital septum and avoid the superficial veins. Application requires specific training in the product's techniques; the manufacturer intends it exclusively for qualified healthcare professionals.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (\"Injection Techniques\" manual and product data sheets of Professional Dietetics S.p.A.). The manufacturer keeps the exact proportions of the formula proprietary. This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Professional Dietetics","offers":[{"title":"Default Title","offer_id":51744928301396,"sku":"","price":98.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/sunekos.jpg?v=1745400819"},{"product_id":"polyphil-next","title":"Croma PolyPhil Next 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eCroma PolyPhil™ Next is the hybrid biostimulator of Croma-Pharma's polynucleotide range: it combines 20 mg of PN-HPT® polynucleotides with 20 mg of non-cross-linked hyaluronic acid in a single 2 ml syringe. Dermal biostimulation and immediate hydration in one product, formulated for mature, dehydrated skin and for the treatment of scars.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 20 mg \/ 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNon-cross-linked HA\u003c\/b\u003e 20 mg \/ 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 3 sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 20 mg per 2 ml syringe (10 mg\/ml), obtained from freshwater trout from controlled European aquaculture, with full traceability of the production chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNon-cross-linked hyaluronic acid:\u003c\/b\u003e 20 mg per 2 ml syringe (10 mg\/ml). This is the distinguishing element of the Next variant compared with classic PolyPhil.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotide High Purification Technology):\u003c\/b\u003e Croma's proprietary purification process, which guarantees a high degree of purity of the polynucleotide chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate fibroblast proliferation and the neosynthesis of collagen and elastin, retain water and act as free-radical scavengers, creating an optimal environment for fibroblast activity. The free hyaluronic acid provides immediate hydration and improves skin quality from the first session.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the PolyPhil range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil\u003c\/th\u003e\u003ctd\u003ePN-HPT® 40 mg \/ 2 ml, without HA — face, neck, décolletage, hands, scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Next\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg + HA 20 mg \/ 2 ml — mature and dehydrated skin, mid third of the face, scars and acne scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — eye contour, eyelids, superficial lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — scalp and eyebrows\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eNote: the PhilArt line was renamed PolyPhil™ in 2024\/2025. It is the same product and the same formulation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eMature and dehydrated skin\u003c\/li\u003e\n\u003cli\u003eMid third of the face\u003c\/li\u003e\n\u003cli\u003eScars and acne scars\u003c\/li\u003e\n\u003cli\u003eFace, neck and dorsum of the hands\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlso indicated as a skin conditioning technique (SET, \u003ci\u003eSkin Enhancement Technique\u003c\/i\u003e) prior to laser treatment, peeling, microneedling or PRP.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal — superficial, mid or deep dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits (multiple puncture), linear retrograde or fanning, with a needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended needle:\u003c\/b\u003e 30G ½\" (13 mm), 2 units included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 2 ml per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 3 sessions at intervals of 14 to 21 days in normal skin; 4 sessions in advanced skin ageing.\u003c\/li\u003e\n\u003cli\u003eCompatible with combined protocols within the PolyPhil range and with other medical aesthetic treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCroma-Pharma GmbH, Austria\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substances\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 10 mg\/ml + non-cross-linked hyaluronic acid 10 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the polynucleotides\u003c\/th\u003e\u003ctd\u003eFreshwater trout, controlled European aquaculture\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eIntradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, in a dry place protected from sunlight. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", user information and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases or a history of them; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders; epilepsy; circulatory disorders; ongoing antibiotic or oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Croma-Pharma. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Croma Pharma","offers":[{"title":"Default Title","offer_id":51746430058836,"sku":"","price":98.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/polyphil.jpg?v=1745412008"},{"product_id":"croma-polyphil-eye","title":"Croma PolyPhil Eye 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eCroma PolyPhil™ Eye is the variant of the Croma-Pharma polynucleotide range formulated for the eye contour: 15 mg of PN-HPT® in a 2 ml syringe, the lowest concentration in the range. The lower polynucleotide load reflects the reduced thickness of the periocular skin, where the aim is to biostimulate without overloading the tissue.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 15 mg \/ 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid\u003c\/b\u003e not contained\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e intradermal\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 15 mg per 2 ml syringe (7.5 mg\/ml), obtained from freshwater trout from controlled European aquaculture, with full traceability of the production chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAdapted concentration:\u003c\/b\u003e it is the formulation with the lowest PN content in the range, together with PolyPhil Hair, designed for thin skin and delicate areas.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotide High Purification Technology):\u003c\/b\u003e Croma's proprietary purification process that guarantees a high degree of purity of the polynucleotide chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate fibroblast proliferation and the neosynthesis of collagen and elastin, retain water and act as free-radical scavengers, creating an optimal environment for fibroblast activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the PolyPhil range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil\u003c\/th\u003e\u003ctd\u003ePN-HPT® 40 mg \/ 2 ml, without HA — face, neck, décolletage, hands, scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Next\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg + HA 20 mg \/ 2 ml — mature and dehydrated skin, midface, scars and acne scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — eye contour, eyelids, superficial lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — scalp and eyebrows\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eNote: the PhilArt line was renamed PolyPhil™ in 2024\/2025. It is the same product and the same formulation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eEye contour and periorbital region\u003c\/li\u003e\n\u003cli\u003eEyelids and brow arch\u003c\/li\u003e\n\u003cli\u003eSuperficial lines of the area\u003c\/li\u003e\n\u003cli\u003eThin, sensitive skin and delicate areas in general\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA biostimulating product, not a volumiser: it acts on the quality and firmness of the skin, it does not fill the tear trough or correct palpebral fat pads.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits (multi-puncture) with a spacing of 0.5 to 1 cm, or linear retrograde.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended needle:\u003c\/b\u003e 30G ½\" (13 mm), 2 units included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 1–2 ml per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 3–4 sessions with an interval of 14 to 21 days.\u003c\/li\u003e\n\u003cli\u003eTake particular care in the periorbital region: superficial injection, small volumes per point and knowledge of the vascular anatomy of the area.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCroma-Pharma GmbH, Austria\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 15 mg per 2 ml syringe (7.5 mg\/ml)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the polynucleotides\u003c\/th\u003e\u003ctd\u003eFreshwater trout, controlled European aquaculture\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eIntradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, in a dry place protected from sunlight. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", information for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases or a history thereof; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders; epilepsy; circulatory disorders; ongoing antibiotic or oncological treatment; under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Croma-Pharma. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Croma Pharma","offers":[{"title":"Default Title","offer_id":51845754913108,"sku":"","price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/polyphil_eye_93b84d73-ae65-4acb-97a5-b20169548aa2.jpg?v=1747075603"},{"product_id":"croma-polyphil","title":"Croma PolyPhil 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eCroma PolyPhil™ is the reference biostimulator of the Croma-Pharma polynucleotide range: 40 mg of PN-HPT® polynucleotides in a 2 ml syringe, \u003cb\u003ewithout hyaluronic acid\u003c\/b\u003e. It is the highest PN concentration in the range and the variant indicated for general skin revitalisation of the face, neck, décolletage, hands and scars.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 40 mg \/ 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid\u003c\/b\u003e not contained\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e intradermal\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 40 mg per 2 ml syringe (20 mg\/ml), obtained from freshwater trout from controlled European aquaculture, with full traceability of the production chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout hyaluronic acid:\u003c\/b\u003e unlike PolyPhil Next, the classic formulation does not incorporate HA. All the active content is polynucleotide, which directs it towards pure biostimulation rather than immediate hydration.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotide High Purification Technology):\u003c\/b\u003e Croma's proprietary purification process that guarantees a high degree of purity of the polynucleotide chain.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate fibroblast proliferation and the neosynthesis of collagen and elastin, retain water and act as free-radical scavengers, creating an optimal environment for fibroblast activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the PolyPhil range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil\u003c\/th\u003e\u003ctd\u003ePN-HPT® 40 mg \/ 2 ml, without HA — face, neck, décolletage, hands, scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Next\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg + HA 20 mg \/ 2 ml — mature and dehydrated skin, midface, scars and acne scars\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — eye contour, eyelids, superficial lines\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePolyPhil Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 15 mg \/ 2 ml — scalp and eyebrows\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eNote: the PhilArt line was renamed PolyPhil™ in 2024\/2025. It is the same product and the same formulation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eWhole face\u003c\/li\u003e\n\u003cli\u003eNeck and décolletage\u003c\/li\u003e\n\u003cli\u003eDorsum of the hands\u003c\/li\u003e\n\u003cli\u003eScars\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEqually indicated as a skin conditioning technique (SET, \u003ci\u003eSkin Enhancement Technique\u003c\/i\u003e) prior to laser, peeling, microneedling or PRP.\u003c\/p\u003e\n\u003cp\u003eNot a volumising product: it improves the quality of the skin without modifying the contour or providing projection.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal — superficial, mid or deep dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits (multi-puncture) with a spacing of approximately 1 cm, linear retrograde or fanning, with a needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRecommended needle:\u003c\/b\u003e 30G ½\" (13 mm), 2 units included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 2 ml per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e a series of sessions spaced 14 to 21 days apart, followed by maintenance sessions. The binding protocol is that of the instructions for use.\u003c\/li\u003e\n\u003cli\u003eCompatible with combined protocols within the PolyPhil range and with other medical aesthetic treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCroma-Pharma GmbH, Austria\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 20 mg\/ml (40 mg per syringe)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the polynucleotides\u003c\/th\u003e\u003ctd\u003eFreshwater trout, controlled European aquaculture\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication plane\u003c\/th\u003e\u003ctd\u003eIntradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eMedical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, in a dry place protected from sunlight. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or resterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", information for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases or a history thereof; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders; epilepsy; circulatory disorders; ongoing antibiotic or oncological treatment; under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Croma-Pharma. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Croma Pharma","offers":[{"title":"Default Title","offer_id":51884560613716,"sku":"","price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/polyphil_442a2f65-7084-445f-a8df-11d901431f42.jpg?v=1747485629"},{"product_id":"newest-one-5x4ml","title":"Newest One 5x4ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eNewest® One is the large-volume presentation of the Newest line from Mastelli S.r.l.: 5 vials of 4 ml with PN-HPT® polynucleotides, non-cross-linked hyaluronic acid and mannitol. It reproduces the principle of Newest — biostimulation and hydration in a single solution — in a diluted formulation designed to treat extensive areas of the face and body.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eActives\u003c\/b\u003e PN-HPT® + non-cross-linked HA\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWith mannitol\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 5 vials × 4 ml (20 ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePlane\u003c\/b\u003e intradermal\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 3–4 sessions \/ 14–21 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eDeclared composition:\u003c\/b\u003e water, PN-HPT® polynucleotides, sodium hyaluronate, mannitol, sodium chloride, sodium phosphate and disodium phosphate.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDiluted formulation:\u003c\/b\u003e this is the low-concentration version of the Newest line, adjusted for the treatment of large surfaces. Mastelli does not publish a single, verifiable mg\/ml figure for this reference; the exact concentrations should be consulted on the pack data sheet. To know precisely the PN-HPT® and hyaluronic acid delivered per session, the documented reference in the line is Newest in a 2 ml syringe (PN-HPT® 10 mg\/ml + HA 10 mg\/ml).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOrigin of the polynucleotides:\u003c\/b\u003e trout gonads from aquaculture intended for human consumption, subjected to Mastelli's proprietary high-purification process, which removes proteins and contaminants of potential allergenic character.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate the fibroblast to synthesise glycosaminoglycans, collagen and elastin and bind water in the extracellular matrix; the non-cross-linked hyaluronic acid provides hydration without generating volume. Mannitol is included as an antioxidant excipient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Mastelli range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePlinest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg\/ml (40 mg \/ 2 ml) — 1 syringe of 2 ml. High concentration: face, neck, décolletage and dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Fast\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml (15 mg \/ 2 ml) — 1 syringe of 2 ml. Low concentration for thin or sensitive skin and for skin preparation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Periocular indication\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Indication for the scalp, eyebrows and beard\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® 2 mg\/ml (8 mg per 4 ml vial) — 5 vials of 4 ml. Diluted formulation for large surfaces and the body\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 10 mg\/ml + non-cross-linked HA 10 mg\/ml + mannitol — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® + non-cross-linked HA + mannitol in diluted formulation — 5 vials of 4 ml, body and large surfaces\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIalest\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 20 mg\/ml (2 %), without polynucleotides — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eNewest One and Plinest One share the same format (5 vials of 4 ml) and large-surface indication; the difference is that Newest One incorporates non-cross-linked hyaluronic acid and mannitol, and Plinest One does not. Plenhyage XL Strong, which is marketed alongside this range, \u003cb\u003edoes not belong to the Mastelli family\u003c\/b\u003e: it is a brand of Bioformula S.r.l.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eDry, dehydrated or dull skin over extensive surfaces\u003c\/li\u003e\n\u003cli\u003eLoss of firmness and elasticity\u003c\/li\u003e\n\u003cli\u003eStretch marks and scars\u003c\/li\u003e\n\u003cli\u003eRevitalisation after procedures and in skin with irregular texture\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eAreas:\u003c\/b\u003e face, neck, décolletage, dorsum of the hands, arms, abdomen, buttocks and inner thighs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits or micropapules, linear retrograde or fanning, according to the area.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e the consensus literature on PN-HPT® recommends 30 to 32G needles of 13 mm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eVial presentation:\u003c\/b\u003e the product is drawn into a syringe before application; the pack does not include pre-filled syringes.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 1 session every 14 or 21 days up to a total of 3 sessions; 4 sessions in advanced signs of ageing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMastelli S.r.l., Sanremo (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substances\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides + non-cross-linked hyaluronic acid (sodium hyaluronate)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOther components\u003c\/th\u003e\u003ctd\u003eMannitol, sodium chloride, sodium phosphate, disodium phosphate, water\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the polynucleotides\u003c\/th\u003e\u003ctd\u003eTrout gonads from aquaculture, highly purified\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e5 vials of 4.0 ml (20 ml in total)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight and heat sources. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product: one vial per session. Do not reuse, re-sterilise or keep the remaining contents of an opened vial.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 5 vials of 4 ml, instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases; active skin infection or inflammation in the treatment area; coagulation disorders or anticoagulant therapy; ongoing oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAs this is a product of fish origin, assess any history of fish allergy before application.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the documentation of Mastelli S.r.l. and on the published clinical literature on PN-HPT®. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Mastelli","offers":[{"title":"Default Title","offer_id":51910452838740,"sku":"","price":92.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/newest_one_bac851a1-33c7-49bf-a28a-6cb88f0c8c65.jpg?v=1747773222"},{"product_id":"croma-pure-ha","title":"Croma Pure HA Facial Mask 4x1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eCroma pure HA is a cosmetic liquid face mask with 1.8 % pure hyaluronic acid and 2 % glycerol. Its formulation is deliberately minimalist — five INCI ingredients, without preservatives or fragrance — and it is presented in single-dose glass syringes that maintain the sterility of the contents until the moment of use. It is a topical cosmetic product, not an injectable.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid\u003c\/b\u003e 1.8 %\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eGlycerol\u003c\/b\u003e 2 %\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 4 × 1 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAction time\u003c\/b\u003e 15 minutes\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout preservatives or fragrance\u003c\/b\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eHyaluronic acid:\u003c\/b\u003e 1.8 % pure concentrated sodium hyaluronate, of pharmaceutical grade.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eGlycerol:\u003c\/b\u003e 2 %, a humectant that retains water in the surface layers of the skin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFull INCI:\u003c\/b\u003e aqua, glycerin, sodium hyaluronate, disodium phosphate, citric acid.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout preservatives, without fragrance, without colourants.\u003c\/b\u003e The absence of preservatives is possible thanks to the sterile single-dose glass packaging; for this reason each syringe is used for a single application.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eUse and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003col\u003e\n\u003cli\u003eCleanse the face and dry without rubbing.\u003c\/li\u003e\n\u003cli\u003eApply the contents of one syringe evenly over the face, neck and décolletage.\u003c\/li\u003e\n\u003cli\u003eLeave to act for 15 minutes.\u003c\/li\u003e\n\u003cli\u003eRinse with lukewarm water.\u003c\/li\u003e\n\u003cli\u003eContinue with the usual cosmetic routine.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eSuitable for all skin types. Topical cosmetic use, suitable both for in-clinic treatment and for home use recommended by the practitioner.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCroma-Pharma GmbH, 2100 Leobendorf, Austria\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCategory\u003c\/th\u003e\u003ctd\u003eCosmetic product — liquid face mask\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eSodium hyaluronate 1.8 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHumectant\u003c\/th\u003e\u003ctd\u003eGlycerol 2 %\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eINCI\u003c\/th\u003e\u003ctd\u003eAqua, glycerin, sodium hyaluronate, disodium phosphate, citric acid\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e4 single-dose glass syringes of 1 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eApplication time\u003c\/th\u003e\u003ctd\u003e15 minutes, with subsequent rinsing\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of use\u003c\/th\u003e\u003ctd\u003eTopical. Not injectable\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e in a dry place, protected from direct sunlight and from heat.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the packaging.\u003c\/li\u003e\n\u003cli\u003eAs it contains no preservatives, each syringe must be used in full after opening and then discarded; do not reuse any remaining contents.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 4 single-dose glass syringes of 1 ml.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eWarnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eFor external use only. Avoid contact with the eyes; in the event of contact, rinse thoroughly with water. Do not apply to damaged or irritated skin or to open wounds. Discontinue use in the event of a skin reaction. Keep out of reach of children.\u003c\/p\u003e\n\u003cp\u003eCosmetic product. It is not a medical device or an injectable product, and it is not intended for any medical indication.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eTopical cosmetic product. Information based on the official documentation of Croma-Pharma. Consult the list of ingredients on the packaging before use.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Croma Pharma","offers":[{"title":"Default Title","offer_id":52041725804884,"sku":"","price":48.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/croma_ha.jpg?v=1749632780"},{"product_id":"rrs-ha-long-lasting-1x3ml","title":"RRS HA Long Lasting 1x3ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eRRS® HA Long Lasting is the reference of the RRS® range from Skin Tech Pharma Group formulated with hyaluronic acid \u003cb\u003ecross-linked with BDDE\u003c\/b\u003e: 21 mg per 3 ml syringe, in an amino acid buffer with hydrating and antioxidant properties. Cross-linking is what sets it apart from the rest of the RRS® range, which consists of free hyaluronic acid solutions; its purpose is to prolong the persistence of the product in the tissue.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA (BDDE)\u003c\/b\u003e 21 mg \/ 3 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 3 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHA origin\u003c\/b\u003e biotechnological, non-animal\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBuffer\u003c\/b\u003e amino acids\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMedical device\u003c\/b\u003e class III\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eHyaluronic acid cross-linked with BDDE:\u003c\/b\u003e 21 mg per 3 ml syringe.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eOrigin:\u003c\/b\u003e hyaluronic acid of biotechnological, non-animal origin.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eProtective buffer:\u003c\/b\u003e amino acids with hydrating and antioxidant properties.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer does not publish the degree of cross-linking or a free hyaluronic acid fraction for this reference; for that reason no value is stated here in this respect. Skin Tech Pharma Group classifies the product as a dermal implant and presents it as the newest addition to its injectables range.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the RRS® range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Long Lasting\u003c\/th\u003e\u003ctd\u003eHA \u003cb\u003ecross-linked with BDDE\u003c\/b\u003e 21 mg \/ 3 ml, amino acid buffer — 1 syringe × 3 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® Hyalift® 75\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 15.0 mg\/ml (75 mg \/ 5 ml), amino acid buffer — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® Hyalift® 75 PROactive\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 15.0 mg\/ml + polyphenols and antioxidants — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Injectable\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 6.0 mg\/ml (30 mg \/ 5 ml), 72 actives — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Eyes\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 5.0 mg\/ml (7.5 mg \/ 1.5 ml) — eye contour — 12 ampoules × 1.5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eXL Hair®\u003c\/th\u003e\u003ctd\u003eHA 0.001 mg\/ml + FGF, GM peptide, sodium DNA — scalp — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eIt is the only cross-linked reference in the range and the only one supplied in an individual pre-filled syringe; the others are free hyaluronic acid solutions in vials or ampoules.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eIndications declared by the manufacturer:\u003c\/b\u003e treatment of cutaneous photoageing and its consequences; dermal atrophy.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFace\u003c\/li\u003e\n\u003cli\u003eNeck and décolleté\u003c\/li\u003e\n\u003cli\u003eDorsum of the hands\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable dermal implant, administered under aseptic conditions on healthy, disinfected skin.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer does not publish in its public documentation the needle gauge, the injection plane, the dose per session or the number of sessions for this reference. The applicable protocol is the one set out in the instructions for use supplied with the pack.\u003c\/p\u003e\n\u003cp\u003eSkin Tech Pharma Group offers AM and PM aftercare serums as a cosmetic complement following the session.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eSkin Tech Pharma Group S.L.U., Spain\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eHyaluronic acid cross-linked with BDDE, 21 mg per 3 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the hyaluronic acid\u003c\/th\u003e\u003ctd\u003eBiotechnological, non-animal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProtective buffer\u003c\/th\u003e\u003ctd\u003eAmino acids with hydrating and antioxidant properties\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003eBox of 1 syringe of 3 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — dermal implant\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked sterile class III medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eMedical use only, in a legally authorised centre\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eBox with 1 sterile syringe of 3 ml.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003eStore as indicated on the pack, protected from direct sunlight and from heat sources.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components or to BDDE; active infection, inflammation or skin lesion in the treatment area; coagulation disorders; autoimmune diseases; pregnancy and breastfeeding; under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer expressly states that the product may only be injected by a legally qualified physician in a legally authorised centre. Always consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Skin Tech Pharma Group. This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Skin Tech Pharma","offers":[{"title":"Default Title","offer_id":52122721386836,"sku":"","price":68.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/rrs_long_lasting_929ef0cf-700e-4bd2-a113-4439e3a5b22a.jpg?v=1773139493"},{"product_id":"rrs-xl-hair-6x5ml","title":"RRS XL Hair 6x5ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eXL Hair® is the hair reference of the RRS® range from Skin Tech Pharma Group: an injectable dermal implant for the scalp whose interest lies not in the hyaluronic acid —present at 0.001 mg\/ml, merely as a vehicle— but in the protective buffer, which combines FGF, GM peptide and sodium DNA with amino acids, trace elements, vitamins, terpenes, fatty acids, flavonoids and antioxidants. Box of 6 vials of 5 ml.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eNon-cross-linked HA\u003c\/b\u003e 0.001 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eKey actives\u003c\/b\u003e FGF, GM peptide, sodium DNA\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 6 vials × 5 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eArea\u003c\/b\u003e scalp\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMedical device\u003c\/b\u003e class III\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eNon-cross-linked hyaluronic acid:\u003c\/b\u003e 0.001 mg\/ml, equivalent to 0.005 mg per 5 ml vial. The concentration is deliberately minimal: here the hyaluronic acid acts as a vehicle, not as an active substance.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eProtective buffer — groups of actives declared by the manufacturer:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFGF (fibroblast growth factor)\u003c\/li\u003e\n\u003cli\u003eGM peptide\u003c\/li\u003e\n\u003cli\u003eSodium DNA\u003c\/li\u003e\n\u003cli\u003eAmino acids\u003c\/li\u003e\n\u003cli\u003eTrace elements\u003c\/li\u003e\n\u003cli\u003eVitamins\u003c\/li\u003e\n\u003cli\u003eTerpenes\u003c\/li\u003e\n\u003cli\u003eFatty acids\u003c\/li\u003e\n\u003cli\u003eFlavonoids and antioxidants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe manufacturer does not publish the individual concentrations of the buffer components; for that reason no numerical values are stated here for any of them.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the RRS® range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eXL Hair®\u003c\/th\u003e\u003ctd\u003eHA 0.001 mg\/ml + FGF, GM peptide, sodium DNA, vitamins and trace elements — scalp — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Injectable\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 6.0 mg\/ml (30 mg \/ 5 ml), 72 actives — face and body — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® Hyalift® 75\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 15.0 mg\/ml (75 mg \/ 5 ml), amino acid buffer — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® Hyalift® 75 PROactive\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 15.0 mg\/ml + polyphenols and antioxidants — 6 vials × 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Eyes\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 5.0 mg\/ml (7.5 mg \/ 1.5 ml) — eye contour — 12 ampoules × 1.5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRRS® HA Long Lasting\u003c\/th\u003e\u003ctd\u003eHA cross-linked with BDDE 21 mg \/ 3 ml — 3 ml syringe\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eIt is the only reference in the range indicated for the scalp and by far the one with the lowest hyaluronic acid concentration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eIndications declared by the manufacturer:\u003c\/b\u003e alopecia and hair restoration; treatment of various patterns of baldness and of symptomatic hair loss.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eScalp\u003c\/li\u003e\n\u003cli\u003eAreas with diffuse or localised loss of density\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable dermal implant for superficial and deep dermal injection. The manufacturer specifies that it must be used under appropriate aseptic conditions, in an authorised centre and on healthy, disinfected skin.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer does not publish in its public documentation the needle gauge, the dose per session or the number of sessions for this reference. The applicable protocol is the one set out in the instructions for use supplied with the pack.\u003c\/p\u003e\n\u003cp\u003eAs a cosmetic aftercare complement, Skin Tech Pharma Group offers the AD Hair, AD ScalpFit and AD Revitalix lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eSkin Tech Pharma Group S.L.U., Spain\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer's designation\u003c\/th\u003e\u003ctd\u003eXL Hair® (RRS® range)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eHyaluronic acid\u003c\/th\u003e\u003ctd\u003eNon-cross-linked, 0.001 mg\/ml (0.005 mg per 5 ml vial)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProtective buffer\u003c\/th\u003e\u003ctd\u003eFGF, GM peptide, sodium DNA, amino acids, trace elements, vitamins, terpenes, fatty acids, flavonoids, antioxidants\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003eBox of 6 vials of 5 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — superficial and deep dermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked sterile class III medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eMedical use only, in a legally authorised centre\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eBox of 6 sterile vials of 5 ml.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003eStore as indicated on the pack, protected from direct sunlight and from heat sources.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; active infection, inflammation or lesion of the scalp in the treatment area; coagulation disorders; autoimmune diseases; pregnancy and breastfeeding; under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer expressly states that the product may only be injected by a legally qualified physician in a legally authorised centre. Always consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Skin Tech Pharma Group. This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Skin Tech Pharma","offers":[{"title":"Default Title","offer_id":52122768441684,"sku":"","price":96.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/rrs_xl_hair.jpg?v=1750624492"},{"product_id":"plinest-fast-1x2ml","title":"Plinest Hair 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003ePlinest® Hair is the variant of the Mastelli range intended for the scalp: PN-HPT® polynucleotides at 7.5 mg\/ml — 15 mg per 2 ml syringe — applied intradermally to act on the perifollicular environment. Its protocol is structured in two phases, with an intensive loading phase followed by a maintenance phase, and it is also used on the eyebrows and beard.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 7.5 mg\/ml (15 mg \/ 2 ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eArea\u003c\/b\u003e scalp, eyebrows and beard\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 2 phases, 4 + 4 sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 7.5 mg\/ml, that is 15 mg per 2 ml syringe.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOrigin:\u003c\/b\u003e trout gonads from aquaculture intended for human consumption, subjected to Mastelli's proprietary high-purification process, which removes proteins and contaminants of potential allergenic character.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotides High Purification Technology):\u003c\/b\u003e technology patented by Mastelli S.r.l., the company that introduced polynucleotides into aesthetic medicine.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e trophic and stimulating action on the dermal tissue of the scalp. The polynucleotides activate the fibroblast to synthesise extracellular matrix, bind water as polyanionic polymers and exert an antioxidant action, creating a more favourable perifollicular environment.\u003c\/li\u003e\n\u003cli\u003eThe formulation contains no hyaluronic acid, growth factors, vitamins or antiandrogenic drugs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Mastelli range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePlinest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg\/ml (40 mg \/ 2 ml) — 1 syringe of 2 ml. High concentration: face, neck, décolletage and dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Fast\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml (15 mg \/ 2 ml) — 1 syringe of 2 ml. Low concentration for thin or sensitive skin and for skin preparation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Periocular indication\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Indication for the scalp, eyebrows and beard\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® 2 mg\/ml (8 mg per 4 ml vial) — 5 vials of 4 ml. Diluted formulation for large surfaces and the body\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 10 mg\/ml + non-cross-linked HA 10 mg\/ml + mannitol — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® + non-cross-linked HA + mannitol in diluted formulation — 5 vials of 4 ml, body and large surfaces\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIalest\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 20 mg\/ml (2 %), without polynucleotides — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eImportant clarification:\u003c\/b\u003e Plinest Hair, Plinest Fast and Plinest Eye declare the same PN-HPT® concentration (7.5 mg\/ml) and the same presentation (2 ml syringe). The difference between them lies in the registered indication, the treatment area and the session protocol, not in the concentration of the active substance. Plenhyage XL Strong, which is marketed alongside this range, \u003cb\u003edoes not belong to the Mastelli family\u003c\/b\u003e: it is a brand of Bioformula S.r.l.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eTrophic stimulation of the scalp\u003c\/li\u003e\n\u003cli\u003eLoss of hair density\u003c\/li\u003e\n\u003cli\u003eDehydrated scalp or scalp with compromised skin quality\u003c\/li\u003e\n\u003cli\u003eTreatment of the eyebrows and beard\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePlinest Hair acts on the dermal environment of the follicle. It does not replace pharmacological treatment of androgenetic alopecia; it is used alone or in combination within a therapeutic plan defined by the clinician.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits, with an infiltration of approximately 0.2 ml per point.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 30G ½\" (13 mm); 2 units included.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTwo-phase protocol:\u003c\/b\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePhase I:\u003c\/b\u003e 4 sessions at intervals of 7 to 14 days.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePhase II:\u003c\/b\u003e 4 further sessions at intervals of 21 to 30 days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMastelli S.r.l., Sanremo (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 7.5 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eContent per syringe\u003c\/th\u003e\u003ctd\u003e15 mg of PN-HPT® in 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the active substance\u003c\/th\u003e\u003ctd\u003eTrout gonads from aquaculture, highly purified\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal in the scalp\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eClass III medical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight and heat sources. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases; active infection or inflammation of the scalp in the treatment area; coagulation disorders or anticoagulant therapy; ongoing oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAs this is a product of fish origin, assess any history of fish allergy before application.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the documentation of Mastelli S.r.l. and on the published clinical literature on PN-HPT®. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Mastelli","offers":[{"title":"Default Title","offer_id":52124970778964,"sku":"","price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/plinest_hair.jpg?v=1754663730"},{"product_id":"revolax-fine-lidocaina","title":"Revolax Fine Lidocaine 1x1.1ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eREVOLAX™ Fine with lidocaine is the most fluid gel in the range of monophasic fillers from Across Co., Ltd. (South Korea). With the same hyaluronic acid concentration as the rest of the line (24 mg\/ml) but a lower degree of cross-linking, it is formulated for the superficial correction of fine lines using a 30G needle, in areas where a dense gel would be visible or palpable.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eCross-linked HA\u003c\/b\u003e 24 mg\/ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine\u003c\/b\u003e 3 mg\/ml (0.3 %)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 1.1 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDuration\u003c\/b\u003e 9–12 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eCross-linked hyaluronic acid:\u003c\/b\u003e 24 mg\/ml, of non-animal origin, obtained by bacterial fermentation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLidocaine hydrochloride:\u003c\/b\u003e 3 mg\/ml (0.3 %), to reduce discomfort during injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCross-linking agent:\u003c\/b\u003e BDDE. The manufacturer states that residual BDDE is removed by a prolonged dialysis process.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHomogeneous monophasic structure:\u003c\/b\u003e the gel is not fractionated into particles of different sizes. In the Fine variant the degree of cross-linking is the lowest in the range, which results in the lowest extrusion force and allows passage through a 30G needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eManufacturing\u003c\/b\u003e under ISO 9001 and ISO 13485 certification.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the REVOLAX range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eThe three variants share the same hyaluronic acid concentration (24 mg\/ml) and lidocaine concentration (0.3 %). What differentiates them is the degree of cross-linking and, with it, the density of the gel, the injection plane and the needle gauge supplied.\u003c\/p\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eVariant\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eFine\u003c\/b\u003e — the most fluid gel\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlane\u003c\/th\u003e\u003ctd\u003eSuperficial to mid dermis\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedle\u003c\/th\u003e\u003ctd\u003e2 × 30G\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIndication\u003c\/th\u003e\u003ctd\u003eFine lines, crow's feet, glabella, perioral and neck wrinkles\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDuration\u003c\/th\u003e\u003ctd\u003e9–12 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eVariant\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eDeep\u003c\/b\u003e — intermediate density\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlane\u003c\/th\u003e\u003ctd\u003eMid to deep dermis \/ superficial subcutaneous\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedle\u003c\/th\u003e\u003ctd\u003e2 × 27G\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIndication\u003c\/th\u003e\u003ctd\u003eNasolabial sulcus, marionette lines, lips, chin, rhinomodelling\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDuration\u003c\/th\u003e\u003ctd\u003e12–18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eVariant\u003c\/th\u003e\u003ctd\u003e\u003cb\u003eSub-Q\u003c\/b\u003e — the densest gel\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlane\u003c\/th\u003e\u003ctd\u003eDeep subcutaneous\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedle\u003c\/th\u003e\u003ctd\u003e2 × 25G\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIndication\u003c\/th\u003e\u003ctd\u003eStructural augmentation of cheekbones, chin, mandibular angle and nasal dorsum\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eDuration\u003c\/th\u003e\u003ctd\u003e12–18 months\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eInjectable hyaluronic acid implant indicated for the correction of fine and superficial wrinkles in adult patients.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePeriorbital lines (crow's feet)\u003c\/li\u003e\n\u003cli\u003eSuperficial glabellar and forehead lines\u003c\/li\u003e\n\u003cli\u003ePerioral wrinkles and barcode lines\u003c\/li\u003e\n\u003cli\u003eSuperficial wrinkles of the neck and décolleté\u003c\/li\u003e\n\u003cli\u003eHydration and definition of the lip contour\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial to mid dermis.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles included:\u003c\/b\u003e 2 units of 30G, sterile and single-use.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e slow injection with constant pressure. Withdraw the needle while continuing to advance in linear retrograde injection or by fanning technique according to the indication.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAspiration prior to injection\u003c\/b\u003e in accordance with standard clinical protocol to reduce the risk of intravascular injection.\u003c\/li\u003e\n\u003cli\u003eManual moulding of the product after injection is recommended in order to even out the distribution.\u003c\/li\u003e\n\u003cli\u003eDo not apply immediately before or after laser, chemical peeling or dermabrasion.\u003c\/li\u003e\n\u003cli\u003eSingle-use product: discard any product remaining in the syringe after the session.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eAcross Co., Ltd. — South Korea\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003eCross-linked hyaluronic acid 24 mg\/ml, non-animal origin\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eAnaesthetic\u003c\/th\u003e\u003ctd\u003eLidocaine HCl 3 mg\/ml (0.3 %)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCross-linker\u003c\/th\u003e\u003ctd\u003eBDDE\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eStructure\u003c\/th\u003e\u003ctd\u003eMonophasic gel, low cross-linking within the range\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 1.1 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked class III medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 1.1 ml, 2 needles 30G, instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications:\u003c\/b\u003e pregnancy and breastfeeding; under 18 years of age; known hypersensitivity to hyaluronic acid, to lidocaine or to amide-type local anaesthetics; tendency to hypertrophic or keloid scarring; active skin inflammation or infection in the treatment area (active acne, herpes); active autoimmune disease; porphyria.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCaution:\u003c\/b\u003e do not apply in areas with pre-existing permanent implants. Avoid simultaneous application with laser, deep chemical peeling or dermabrasion. Assess individually in patients on anticoagulant or antiplatelet therapy and in patients with a history of severe allergic reactions.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eNever inject intravascularly.\u003c\/b\u003e Always consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on documentation from the manufacturer Across Co., Ltd. and from the official distribution of the REVOLAX brand. This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"ACROSS","offers":[{"title":"Default Title","offer_id":52514889335124,"sku":null,"price":38.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/revolax_fine_0539ed88-9a58-4e74-a02f-dc0e133ecb67.jpg?v=1756641506"},{"product_id":"plinest-fast","title":"Plinest Fast 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003ePlinest® Fast is the low-concentration variant of the Mastelli range: PN-HPT® polynucleotides at 7.5 mg\/ml — 15 mg per 2 ml syringe — compared with the 20 mg\/ml of classic Plinest. The lower density of the solution allows a faster and more comfortable superficial intradermal infiltration, which positions it for thin or sensitive skin and for skin preparation protocols. It contains no hyaluronic acid.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 7.5 mg\/ml (15 mg \/ 2 ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout hyaluronic acid\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 3–4 sessions \/ 14–21 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 7.5 mg\/ml, that is 15 mg per 2 ml syringe. This is the low concentration of the Plinest line.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOrigin:\u003c\/b\u003e trout gonads from aquaculture intended for human consumption, subjected to Mastelli's proprietary high-purification process, which removes proteins and contaminants of potential allergenic character.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotides High Purification Technology):\u003c\/b\u003e technology patented by Mastelli S.r.l., the company that introduced polynucleotides into aesthetic medicine.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate the dermal fibroblast to synthesise glycosaminoglycans, collagen and elastin; as polyanionic polymers they bind water in the extracellular matrix and exert an antioxidant action.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout hyaluronic acid or anaesthetic.\u003c\/b\u003e Anyone seeking the combination of polynucleotides with hyaluronic acid within this range should use Newest (PN-HPT® 10 mg\/ml + HA 10 mg\/ml), not Plinest Fast.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Mastelli range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePlinest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg\/ml (40 mg \/ 2 ml) — 1 syringe of 2 ml. High concentration: face, neck, décolletage and dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Fast\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml (15 mg \/ 2 ml) — 1 syringe of 2 ml. Low concentration for thin or sensitive skin and for skin preparation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Periocular indication\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Indication for the scalp, eyebrows and beard\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® 2 mg\/ml (8 mg per 4 ml vial) — 5 vials of 4 ml. Diluted formulation for large surfaces and the body\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 10 mg\/ml + non-cross-linked HA 10 mg\/ml + mannitol — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® + non-cross-linked HA + mannitol in diluted formulation — 5 vials of 4 ml, body and large surfaces\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIalest\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 20 mg\/ml (2 %), without polynucleotides — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eImportant clarification:\u003c\/b\u003e Plinest Fast, Plinest Eye and Plinest Hair declare the same PN-HPT® concentration (7.5 mg\/ml) and the same presentation (2 ml syringe). The difference between them lies in the registered indication, the treatment area and the session protocol, not in the concentration of the active substance. Plenhyage XL Strong, which is marketed alongside this range, \u003cb\u003edoes not belong to the Mastelli family\u003c\/b\u003e: it is a brand of Bioformula S.r.l.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eThin, sensitive or reactive skin\u003c\/li\u003e\n\u003cli\u003eFine lines, irregular texture and loss of radiance\u003c\/li\u003e\n\u003cli\u003eEarly skin ageing\u003c\/li\u003e\n\u003cli\u003eAcne scars and post-acne sequelae\u003c\/li\u003e\n\u003cli\u003eSkin preparation (\u003ci\u003epriming\u003c\/i\u003e) and recovery after laser treatment, microneedling, peeling or radiofrequency\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eAreas:\u003c\/b\u003e face, neck, décolletage and dorsum of the hands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits or micropapules (multiple puncture, \u003ci\u003enappage\u003c\/i\u003e) and linear retrograde threading in folds.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 30G ½\" (13 mm); 2 units included. In delicate areas finer gauges are commonly used, according to the clinician's practice.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 2 ml per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 3 to 4 sessions at intervals of 14 to 21 days.\u003c\/li\u003e\n\u003cli\u003eAs a preparation protocol before another procedure, 1 to 4 sessions are used, starting approximately one month beforehand.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMastelli S.r.l., Sanremo (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 7.5 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eContent per syringe\u003c\/th\u003e\u003ctd\u003e15 mg of PN-HPT® in 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the active substance\u003c\/th\u003e\u003ctd\u003eTrout gonads from aquaculture, highly purified\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eClass III medical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight and heat sources. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders or anticoagulant therapy; ongoing oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAs this is a product of fish origin, assess any history of fish allergy before application.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the documentation of Mastelli S.r.l. and on the published clinical literature on PN-HPT®. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Mastelli","offers":[{"title":"Default Title","offer_id":52544356352340,"sku":null,"price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/plinestfast.png?v=1756999401"},{"product_id":"plinest-1x2ml","title":"Plinest 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003ePlinest® is the reference biorevitaliser from Mastelli S.r.l. (Sanremo, Italy), the company that developed and patented PN-HPT® technology (Polynucleotides High Purification Technology). It contains highly purified polynucleotides at 20 mg\/ml — 40 mg per 2 ml syringe — the highest concentration in the Plinest range. It is not a filler: it does not provide volume, but acts on the fibroblast to improve the quality, density and elasticity of the skin.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 20 mg\/ml (40 mg \/ 2 ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout hyaluronic acid\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 3–4 sessions \/ 14–21 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 20 mg\/ml, that is 40 mg per 2 ml syringe. This is the highest concentration in the Plinest line.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOrigin:\u003c\/b\u003e trout gonads from aquaculture intended for human consumption. The material undergoes Mastelli's proprietary high-purification process, which removes proteins and contaminants of potential allergenic character.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotides High Purification Technology):\u003c\/b\u003e technology patented by Mastelli, the company that introduced polynucleotides into aesthetic medicine. The polynucleotide chains retain a high molecular weight and a high degree of purity after sterilisation.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate the dermal fibroblast to synthesise new matrix glycosaminoglycans and collagen and elastin fibres. As polyanionic polymers, they bind water and keep the extracellular matrix hydrated over prolonged periods, in addition to exerting an antioxidant action against free radicals.\u003c\/li\u003e\n\u003cli\u003eThe formulation contains neither hyaluronic acid nor anaesthetic.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Mastelli range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePlinest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg\/ml (40 mg \/ 2 ml) — 1 syringe of 2 ml. High concentration: face, neck, décolletage and dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Fast\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml (15 mg \/ 2 ml) — 1 syringe of 2 ml. Low concentration for thin or sensitive skin and for skin preparation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Periocular indication\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Indication for the scalp, eyebrows and beard\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® 2 mg\/ml (8 mg per 4 ml vial) — 5 vials of 4 ml. Diluted formulation for large surfaces and the body\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 10 mg\/ml + non-cross-linked HA 10 mg\/ml + mannitol — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® + non-cross-linked HA + mannitol in diluted formulation — 5 vials of 4 ml, body and large surfaces\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIalest\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 20 mg\/ml (2 %), without polynucleotides — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003ePlinest Fast, Plinest Eye and Plinest Hair declare the \u003cb\u003esame PN-HPT® concentration (7.5 mg\/ml) in the same 2 ml presentation\u003c\/b\u003e: they differ by registered indication and by session protocol, not by the concentration of the active substance. Plenhyage XL Strong, which is marketed alongside this range, \u003cb\u003edoes not belong to the Mastelli family\u003c\/b\u003e: it is a brand of Bioformula S.r.l.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eLoss of skin elasticity, firmness and density\u003c\/li\u003e\n\u003cli\u003eFine lines and superficial wrinkles\u003c\/li\u003e\n\u003cli\u003ePhotoageing and dehydrated skin\u003c\/li\u003e\n\u003cli\u003eScars, including the sequelae of acne\u003c\/li\u003e\n\u003cli\u003eSkin remodelling in areas with a higher fibrous content\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eAreas:\u003c\/b\u003e face, neck, décolletage and dorsum of the hands.\u003c\/p\u003e\n\u003cp\u003eAlso used as skin preparation (\u003ci\u003epriming\u003c\/i\u003e) before laser treatment, chemical peeling, microneedling, radiofrequency or carboxytherapy, and in combination with other medical aesthetic procedures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits (multiple puncture) or linear retrograde threading with a needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 30G ½\" (13 mm); 2 units included. The consensus literature on PN-HPT® recommends 30 to 32G needles of 13 mm.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eDose:\u003c\/b\u003e 2 ml per session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 3 to 4 sessions at intervals of 14 to 21 days.\u003c\/li\u003e\n\u003cli\u003eAs a preparation protocol before another procedure, 1 to 4 sessions are used, starting approximately one month beforehand.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMastelli S.r.l., Sanremo (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 20 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eContent per syringe\u003c\/th\u003e\u003ctd\u003e40 mg of PN-HPT® in 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the active substance\u003c\/th\u003e\u003ctd\u003eTrout gonads from aquaculture, highly purified\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eClass III medical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight and heat sources. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders or anticoagulant therapy; ongoing oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAs this is a product of fish origin, assess any history of fish allergy before application.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the documentation of Mastelli S.r.l. and on the published clinical literature on PN-HPT®. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Mastelli","offers":[{"title":"Default Title","offer_id":52602758824276,"sku":null,"price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/plinest.jpg?v=1757942949"},{"product_id":"plinest-eye-1x2ml","title":"Plinest Eye 1x2ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003ePlinest® Eye is the variant of the Mastelli range formulated for the eye contour: PN-HPT® polynucleotides at 7.5 mg\/ml in a 2 ml pre-filled syringe. The reduced concentration — compared with the 20 mg\/ml of Plinest — reflects the lesser thickness and greater fragility of periocular skin and allows a superficial intradermal infiltration, without adding volume.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT®\u003c\/b\u003e 7.5 mg\/ml (15 mg \/ 2 ml)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eWithout hyaluronic acid\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eContents\u003c\/b\u003e 1 syringe × 2 ml\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 2 × 30G ½\"\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e 3–4 sessions \/ 14–21 days\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and technology\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® polynucleotides:\u003c\/b\u003e 7.5 mg\/ml, that is 15 mg per 2 ml syringe.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOrigin:\u003c\/b\u003e trout gonads from aquaculture intended for human consumption, subjected to Mastelli's proprietary high-purification process, which removes proteins and contaminants of potential allergenic character.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePN-HPT® (Polynucleotides High Purification Technology):\u003c\/b\u003e technology patented by Mastelli S.r.l., the company that introduced polynucleotides into aesthetic medicine.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism of action:\u003c\/b\u003e the polynucleotides stimulate the dermal fibroblast to synthesise glycosaminoglycans, collagen and elastin; as polyanionic polymers they bind water in the extracellular matrix and exert an antioxidant action against free radicals.\u003c\/li\u003e\n\u003cli\u003eThe formulation contains neither hyaluronic acid nor anaesthetic.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Mastelli range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003ePlinest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 20 mg\/ml (40 mg \/ 2 ml) — 1 syringe of 2 ml. High concentration: face, neck, décolletage and dorsum of the hands\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Fast\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml (15 mg \/ 2 ml) — 1 syringe of 2 ml. Low concentration for thin or sensitive skin and for skin preparation\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Eye\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Periocular indication\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest Hair\u003c\/th\u003e\u003ctd\u003ePN-HPT® 7.5 mg\/ml — 1 syringe of 2 ml. Indication for the scalp, eyebrows and beard\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePlinest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® 2 mg\/ml (8 mg per 4 ml vial) — 5 vials of 4 ml. Diluted formulation for large surfaces and the body\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest\u003c\/th\u003e\u003ctd\u003ePN-HPT® 10 mg\/ml + non-cross-linked HA 10 mg\/ml + mannitol — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNewest One\u003c\/th\u003e\u003ctd\u003ePN-HPT® + non-cross-linked HA + mannitol in diluted formulation — 5 vials of 4 ml, body and large surfaces\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eIalest\u003c\/th\u003e\u003ctd\u003eNon-cross-linked HA 20 mg\/ml (2 %), without polynucleotides — 1 syringe of 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eImportant clarification:\u003c\/b\u003e Plinest Eye, Plinest Fast and Plinest Hair declare the same PN-HPT® concentration (7.5 mg\/ml) and the same presentation (2 ml syringe). The difference between them lies in the registered indication, the treatment area and the session protocol, not in the concentration of the active substance. Plenhyage XL Strong, which is marketed alongside this range, \u003cb\u003edoes not belong to the Mastelli family\u003c\/b\u003e: it is a brand of Bioformula S.r.l.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eLoss of firmness and elasticity in periocular skin\u003c\/li\u003e\n\u003cli\u003eFine lines and superficial wrinkles of the eye contour\u003c\/li\u003e\n\u003cli\u003eThin, dehydrated or tired-looking skin in the periorbital area\u003c\/li\u003e\n\u003cli\u003eImprovement of the texture and skin quality of the lower eyelid\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eAreas:\u003c\/b\u003e eye contour and periocular region.\u003c\/p\u003e\n\u003cp\u003eDark circles of vascular or structural origin (palpebral groove, eye bags) are not corrected with polynucleotides; the indication is skin quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and treatment protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e superficial intradermal.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e microdeposits (multiple puncture) or linear retrograde threading with a needle.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedle:\u003c\/b\u003e 30G ½\" (13 mm); 2 units included. In the periocular area finer gauges (32G) are commonly used according to the clinician's practice.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol:\u003c\/b\u003e 3 to 4 sessions at intervals of 14 to 21 days.\u003c\/li\u003e\n\u003cli\u003eCompatible with combined protocols within the Plinest range and with other medical aesthetic treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eMastelli S.r.l., Sanremo (Italy)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePN-HPT® polynucleotides 7.5 mg\/ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eContent per syringe\u003c\/th\u003e\u003ctd\u003e15 mg of PN-HPT® in 2 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eOrigin of the active substance\u003c\/th\u003e\u003ctd\u003eTrout gonads from aquaculture, highly purified\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e1 pre-filled syringe of 2.0 ml\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e2 × 30G ½\" (13 mm)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute of administration\u003c\/th\u003e\u003ctd\u003eInjectable — intradermal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eClass III medical device with CE marking 0373\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e between 2 °C and 25 °C, protected from direct sunlight and heat sources. Do not freeze.\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date shown on the pack.\u003c\/li\u003e\n\u003cli\u003eSterile single-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 1 pre-filled syringe of 2 ml, 2 needles 30G ½\", instructions for use and traceability labels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eKnown hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases; active skin infection or inflammation in the treatment area, including active herpes simplex; coagulation disorders or anticoagulant therapy; ongoing oncological treatment; patients under 18 years of age.\u003c\/p\u003e\n\u003cp\u003eAs this is a product of fish origin, assess any history of fish allergy before application. The periocular area requires particular care with the depth of injection and the management of vascular risk.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the documentation of Mastelli S.r.l. and on the published clinical literature on PN-HPT®. This data sheet does not replace the instructions for use accompanying the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Mastelli","offers":[{"title":"Default Title","offer_id":52602905624916,"sku":null,"price":88.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/plinest_eye.jpg?v=1757943801"},{"product_id":"linerase-restoring-mask","title":"Linerase Restoring Mask","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eLinerase® Restoring Mask is the soothing cosmetic mask that the manufacturer includes in the protocol following Linerase® Collagen sessions: it is applied to the treated area and left on for 10 minutes. Formulated with zinc oxide, sodium hyaluronate, aloe, calendula, witch hazel and bisabolol, in a 50 ml tube. Topical product, not injectable.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eType\u003c\/b\u003e cosmetic mask\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFormat\u003c\/b\u003e 50 ml tube\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eExposure time\u003c\/b\u003e 10 minutes\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eUse\u003c\/b\u003e after the session\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eRoute\u003c\/b\u003e topical\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eMain actives and ingredients according to the INCI labelling:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eZinc Oxide\u003c\/b\u003e — protective and soothing effect on the treated skin.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSodium Hyaluronate\u003c\/b\u003e — sodium hyaluronate, moisturising component.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAloe Barbadensis Leaf Juice\u003c\/b\u003e — aloe vera juice.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eCalendula Officinalis Extract\u003c\/b\u003e — calendula extract.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eHamamelis Virginiana Leaf Extract\u003c\/b\u003e — witch hazel extract.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBisabolol\u003c\/b\u003e and \u003cb\u003eTocopheryl Acetate\u003c\/b\u003e (vitamin E) — soothing and antioxidant.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOlive Oil\u003c\/b\u003e, \u003cb\u003eIsopropyl Palmitate\u003c\/b\u003e, \u003cb\u003eParaffinum Liquidum\u003c\/b\u003e, \u003cb\u003eCetearyl Alcohol\u003c\/b\u003e, \u003cb\u003ePEG-100 Stearate\u003c\/b\u003e, \u003cb\u003ePropylene Glycol\u003c\/b\u003e, \u003cb\u003eAqua\u003c\/b\u003e — emollient and emulsifying base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe complete, current INCI list is given on the packaging and prevails over this list.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003ePosition within the Linerase range\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eLinerase® Collagen\u003c\/th\u003e\u003ctd\u003eHeterologous type I collagen of equine origin, 100 mg in powder form. Injectable medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLinerase® Hydro\u003c\/th\u003e\u003ctd\u003eNon-cross-linked hyaluronic acid at 1 % with amino acids. Injectable medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLinerase® Medical White Peel\u003c\/th\u003e\u003ctd\u003eProfessional topical peel in a three-step set\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLinerase® Restoring Mask\u003c\/th\u003e\u003ctd\u003eTopical cosmetic mask. Provided for in the manufacturer's protocol at the end of the session\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eLinerase® Collagen Daily\u003c\/th\u003e\u003ctd\u003ePowdered food supplement, oral route\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cb\u003eClassification note:\u003c\/b\u003e Restoring Mask is a cosmetic product for topical application. It contains no injectable heterologous collagen and does not share the regulatory framework of the medical devices in the range.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003ePost-procedure care: soothes, hydrates and supports skin recovery after aesthetic medicine treatments.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eUse intended by the manufacturer:\u003c\/b\u003e application at the end of the Linerase® Collagen session over the treated area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eAreas:\u003c\/b\u003e face and other treated areas, at the professional's discretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eDirections for use\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003eApply the mask to the treated area at the end of the session.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eLeave on for 10 minutes.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003eRemove with a moistened cosmetic pad.\u003c\/li\u003e\n\u003cli\u003eFor external use only. Avoid contact with the eyes and mucous membranes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eCSD S.r.l., Rome (Italy) — Linerase brand\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eCategory\u003c\/th\u003e\u003ctd\u003eCosmetic product for topical use\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eKey ingredients\u003c\/th\u003e\u003ctd\u003eZinc oxide, sodium hyaluronate, aloe vera, calendula, witch hazel, bisabolol, tocopheryl acetate\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e50 ml tube\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eExposure time\u003c\/th\u003e\u003ctd\u003e10 minutes\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRemoval\u003c\/th\u003e\u003ctd\u003eMoistened cosmetic pad\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eRoute\u003c\/th\u003e\u003ctd\u003eTopical. Not injectable\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eStorage:\u003c\/b\u003e at room temperature, protected from direct light and heat sources.\u003c\/li\u003e\n\u003cli\u003eObserve the period after opening (PAO) stated on the packaging.\u003c\/li\u003e\n\u003cli\u003eDo not use after the stated expiry date.\u003c\/li\u003e\n\u003cli\u003eExternal use. Do not apply to open wounds or mucous membranes. Discontinue use in the event of a skin reaction.\u003c\/li\u003e\n\u003cli\u003eCheck the INCI list on the packaging in case of known allergy to any of the ingredients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eCosmetic product for topical use. Information based on the product documentation of CSD S.r.l. (Linerase brand) and on the Linerase® Collagen protocol published by the manufacturer. The INCI list and the instructions on the packaging prevail over this data sheet.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"SCD","offers":[{"title":"Default Title","offer_id":53455120073044,"sku":null,"price":36.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/linerase_restoring_mask_91b59a6e-11d7-449a-a2c7-f4a91f791d2e.jpg?v=1769342657"}],"url":"https:\/\/pieleterna.es\/en\/collections\/en-stock.oembed","provider":"Piel Eterna","version":"1.0","type":"link"}